Form 10-Q Q1 FY19

0000943819-18-000016.txt : 20181026 0000943819-18-000016.hdr.sgml : 20181026 20181025191822 ACCESSION NUMBER: 0000943819-18-000016 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 181140036 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 10-Q 1 rmd-20180930x10q.htm 10-Q Form 10-Q Q1 FY19

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

______________________________________________________________________________________________

FORM 10-Q

______________________________________________________________________________________________

(Mark One)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-15317

______________________________________________________________________________________________

ResMed Inc.

(Exact name of registrant as specified in its charter)

______________________________________________________________________________________________

Delaware

(State or other jurisdiction of incorporation or organization)

98-0152841

(I.R.S. Employer Identification No.)

9001 Spectrum Center Blvd.

San Diego, CA 92123

United States of America

(Address of principal executive offices)

(858) 836-5000

(Registrant’s telephone number, including area code)

______________________________________________________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Yes ☐ No ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At October 22, 2018, there were 142,499,749 shares of Common Stock ($0.004 par value) outstanding. This number excludes 41,836,234 shares held by the registrant as treasury shares.

Table of Contents

RESMED INC. AND SUBSIDIARIES

Index


Part I	Financial Information	3

Item 1	Financial Statements	3

	Condensed Consolidated Balance Sheets (Unaudited)	3

	Condensed Consolidated Statements of Income (Unaudited)	4

	Condensed Consolidated Statements of Comprehensive Income (Unaudited)	5

	Condensed Consolidated Statements of Cash Flows (Unaudited)	6

	Notes to the Condensed Consolidated Financial Statements (Unaudited)	7

Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18

Item 3	Quantitative and Qualitative Disclosures About Market Risk	26

Item 4	Controls and Procedures	28

Part II	Other Information	29

Item 1	Legal Proceedings	29

Item 1A	Risk Factors	29

Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	30

Item 3	Defaults Upon Senior Securities	30

Item 4	Mine Safety Disclosures	30

Item 5	Other Information	30

Item 6	Exhibits	31

	Signatures	32

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

Item 1. Financial Statements

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(In US$ thousands, except share and per share data)



	September 30, 2018		June 30, 2018
Assets
Current assets:
Cash and cash equivalents	$	230,188	$	188,701
Accounts receivable, net of allowance for doubtful accounts of $21,928 and $19,258 at September 30, 2018 and June 30, 2018, respectively		463,743		483,681
Inventories (note 2)		282,555		268,701
Prepaid expenses and other current assets		111,757		124,634
Total current assets		1,088,243		1,065,717
Non-current assets:
Property, plant and equipment, net (note 3)		381,822		386,550
Goodwill (note 4)		1,192,030		1,068,944
Other intangible assets, net (note 5)		242,193		215,184
Deferred income taxes		46,226		53,818
Prepaid taxes and other non-current assets		117,024		273,710
Total non-current assets		1,979,295		1,998,206
Total assets	$	3,067,538	$	3,063,923
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	98,709	$	92,723
Accrued expenses		169,465		185,805
Deferred revenue		64,822		60,828
Income taxes payable (note 7)		76,137		160,427
Short-term debt, net (note 9)		11,975		11,466
Total current liabilities		421,108		511,249
Non-current liabilities:
Deferred revenue		73,810		71,596
Deferred income taxes		16,091		13,084
Other long-term liabilities		534		924
Long-term debt, net (note 9)		517,637		269,988
Long-term income taxes payable (note 7)		138,102		138,102
Total non-current liabilities		746,174		493,694
Total liabilities		1,167,282		1,004,943
Commitments and contingencies (note 13)
Stockholders’ equity: (note 10)
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued		-		-
Common stock, $0.004 par value, 350,000,000 shares authorized; 184,330,350 issued and 142,494,116 outstanding at September 30, 2018 and 184,315,866 issued and 142,679,632 outstanding at June 30, 2018		570		571
Additional paid-in capital		1,463,669		1,450,821
Retained earnings		2,296,473		2,432,328
Treasury stock, at cost, 41,836,234 shares at September 30, 2018 and 41,636,234 shares at June 30, 2018		(1,623,256)		(1,600,412)
Accumulated other comprehensive loss		(237,200)		(224,328)
Total stockholders’ equity		1,900,256		2,058,980
Total liabilities and stockholders’ equity	$	3,067,538	$	3,063,923

See the accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Unaudited)

(In US$ thousands, except per share data)



	Three Months Ended September 30,
	2018		2017

Net revenue	$	588,279	$	523,659
Cost of sales (excluding amortization of acquired intangible assets)		245,186		218,054
Gross profit		343,093		305,605
Operating expenses:
Selling, general and administrative		147,303		143,849
Research and development		38,791		37,415
Amortization of acquired intangible assets		12,867		11,783
Total operating expenses		198,961		193,047
Income from operations		144,132		112,558
Other income (loss), net:
Interest income		922		4,870
Interest expense		(3,708)		(7,785)
Other, net		(2,465)		(1,158)
Total other income (loss), net		(5,251)		(4,073)

Income before income taxes		138,881		108,485
Income taxes		33,144		22,360
Net income	$	105,737	$	86,125

Basic earnings per share (note 11)	$	0.74	$	0.61
Diluted earnings per share (note 11)	$	0.73	$	0.60
Dividend declared per share	$	0.37	$	0.35
Basic shares outstanding (000's)		142,668		142,247
Diluted shares outstanding (000's)		144,030		143,480

See the accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

(In US$ thousands)



	Three Months Ended September 30,
	2018		2017
Net income	$	105,737	$	86,125
Other comprehensive income (loss):
Foreign currency translation (loss) gain adjustments		(12,872)		36,389
Comprehensive income (loss)	$	92,865	$	122,514

See the accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In US$ thousands)



	Three Months Ended September 30,
	2018		2017
Cash flows from operating activities:
Net income	$	105,737	$	86,125
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		30,424		29,571
Stock-based compensation costs		12,477		11,948
Impairment of equity investments		1,711		962
Changes in fair value of business combination contingent consideration (note 12)		(183)		-
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		20,342		23,317
Inventories		(15,661)		(26,942)
Prepaid expenses, net deferred income taxes and other current assets		(7,703)		(15,408)
Accounts payable, accrued expenses and other		(99,025)		(15,590)
Net cash provided by operating activities		48,119		93,983
Cash flows from investing activities:
Purchases of property, plant and equipment		(12,994)		(16,030)
Patent registration costs		(2,611)		(2,242)
Business acquisitions, net of cash acquired		(126,439)		-
Investment in equity investments		(2,467)		(3,225)
Proceeds (payments) on maturity of foreign currency contracts		(3,678)		6,073
Net cash used in investing activities		(148,189)		(15,424)
Cash flows from financing activities:
Proceeds from issuance of common stock, net		389		3,615
Purchases of treasury stock		(19,399)		-
Payments of business combination contingent consideration (note 12)		(240)		-
Proceeds from borrowings, net of borrowing costs		303,000		50,000
Repayment of borrowings		(86,133)		(110,000)
Dividend paid		(52,793)		(49,698)
Net cash provided by (used in) financing activities		144,824		(106,083)
Effect of exchange rate changes on cash		(3,267)		16,691
Net increase (decrease) in cash and cash equivalents		41,487		(10,833)
Cash and cash equivalents at beginning of period		188,701		821,935
Cash and cash equivalents at end of period	$	230,188	$	811,102
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	$	125,005	$	30,157
Interest paid	$	3,708	$	7,785

Fair value of assets acquired, excluding cash	$	42,807	$	-
Liabilities assumed		(41,905)		-
Goodwill on acquisition		125,037		-
Deferred payments		500		-
Cash paid for acquisition	$	126,439	$	-

See the accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(1) Summary of Significant Accounting Policies

Organization and Basis of Presentation

ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Norway and Sweden.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2019.

The condensed consolidated financial statements for the three months ended September 30, 2018 and September 30, 2017 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2018.

Revenue Recognition

We adopted Accounting Standard Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” on July 1, 2018. We account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. Our revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and data for patient monitoring. Our software as a service (“SaaS”) business offers software access with ongoing support and maintenance services as well as professional services such as training and consulting.

Disaggregation of revenue

We have determined that we predominantly operate in a single operating segment, which is the sleep and respiratory disorders sector of the medical device industry. Due to the acquisition of Brightree LLC (“Brightree”) in April 2016, our operations now include the supply of SaaS to medical equipment and home health providers. However, these SaaS operations, both in terms of revenue and profit, are not material to our global operations and have not been separately reported. The following table summarizes our net revenue disaggregated by product and region for the three months ended September 30, 2018 compared to September 30, 2017 (in millions):



	Three Months Ended September 30,
	2018		2017
U.S., Canada and Latin America
Devices	$	172.4	$	157.9
Masks		154.0		138.7
Total devices and masks	$	326.4	$	296.6
Software as a Service		47.5		38.1
Total	$	373.9	$	334.7

Combined Europe, Asia and other markets
Devices	$	151.7	$	128.3
Masks		62.7		60.7
Total	$	214.4	$	189.0

Global revenue
Devices	$	324.1	$	286.2
Masks		216.7		199.4
Total devices and masks	$	540.8	$	485.6
Software as a Service		47.5		38.1
Total	$	588.3	$	523.7

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Performance obligations and contract balances

Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of risk and/or control of our products are provided at a point in time. For most products, we transfer control and recognize a sale when products are shipped from our manufacturing facility or warehouse to the customer. For contracts with customers that contain destination shipping terms, revenue is not recognized until risk has transferred and the goods are delivered to the agreed upon destination. Depending on the terms of the arrangement, we will defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue relate primarily to the provision of software access with maintenance and support, extended warranties on our devices and provision of data for patient monitoring. Generally, deferred revenue will be recognized over a period of one to five years. The following table summarizes our contract balances at September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018		Balance sheet caption
Contract assets
Accounts receivable, net	$	463,743	$	483,681	Accounts receivable, net
Unbilled revenue, current		12,861		13,342	Prepaid expenses and other current assets
Unbilled revenue, non-current		3,718		2,973	Prepaid taxes and other non-current assets

Contract liabilities
Deferred revenue, current		(64,822)		(60,828)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(73,810)		(71,596)	Deferred revenue (non-current liabilities)

Transaction price determination

Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The amount of consideration received and revenue recognized varies with changes in marketing incentives (e.g., rebates, discounts, free goods) and returns offered to customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed.

We offer our customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer’s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. We also offer discounts to customers as part of normal business practice and these are deducted from revenue when the sale occurs.

Many of our contracts have a single performance obligation which is the shipment of our therapy-based equipment. However, when the contract has multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to the performance obligation.

Accounting and practical expedient elections

We have elected to account for shipping and handling activities as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue. We have adopted two practical expedients including the “right to invoice” practical expedient, which allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date and which is relevant for some of our SaaS contracts. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less.

Provision for Warranty

We provide for the estimated cost of product warranties at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

New Accounting Pronouncements

(a) Recently issued accounting standards not yet adopted

ASU No. 2016-02, “Leases”

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842). Under the new guidance, lessees are required to recognize a right-of-use asset and a lease liability on the balance sheet for all leases, other than those that meet the definition of a short-term lease. This update will establish a lease asset and lease liability by lessees for those leases classified as operating under current GAAP. Leases will be classified as either operating or finance under the new guidance. Operating leases will result in straight-line expense in the income statement, similar to current operating leases, and finance leases will result in more expense being recognized in the earlier years of the lease term, similar to current capital leases. For lessors, the update will more closely align lease accounting to comparable guidance in the new revenue standards described.

The new standard is effective for us beginning in the first quarter of the year ending June 30, 2020 and early application is permitted. ASU 2016-02 will be adopted on a modified retrospective transition basis. There is a practical expedient available that would permit any leases that existed at the date of adoption to continue to be accounted for in accordance with the previous GAAP, ASC 840. We are still evaluating whether we will adopt this practical expedient.

We formed an implementation team during the year ended June 30, 2018 to oversee adoption of the new standard. The implementation team has established a project plan as well as initiated collecting global data on our lease agreements. There are a number of steps in the team’s project plan that remain to be completed including: executing global education program, designing the system solution for data collation and balance calculations, evaluating the impact, and working through required changes to systems, business processes and controls to support the adoption of the new leases standard. While the formal impact assessment is ongoing, we expect this amendment will affect the way we account for operating leases where we are the lessee (as described above), require reassessment of how we account for revenue where we are the lessor and will result in increased disclosures for all lease arrangements. We are still evaluating the impact the standard will have on our financial statements.

(b) Recently adopted accounting pronouncements

ASU No. 2014-09, “Revenue from Contracts with Customers”

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. Since its initial release, the FASB has issued several amendments to the standard, which include clarification of accounting guidance related to identification of performance obligations, intellectual property licenses, and principal vs. agent considerations. ASU 2014-09 and all subsequent amendments (collectively, the “new revenue recognition standards”) replaced most existing revenue recognition guidance in U.S. GAAP during the current quarter when it became effective. The guidance also requires improved disclosures on the nature, amount, timing, and uncertainty of revenue that is recognized.

Effective July 1, 2018, we adopted the new revenue recognition standards and applied its provisions to all contracts using the modified retrospective method. Application of the new provisions did not have a material impact on our financial statements and no cumulative-effect adjustment was calculated or recognized. The comparative information has not been restated; however, if it were there would be no change in the accounting treatment. Refer to the “Revenue Recognition” section above for further details about our revenue recognition following adoption of the new revenue recognition standards.

ASU No. 2016-01, "Financial Instruments - Overall"

In January 2016, the FASB issued ASU No. 2016-01, "Financial Instruments - Overall" (Topic 825-10). The amendments address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments, and require equity investments, other than equity-method investments, to be measured at fair value with changes in fair value recognized through net income. The amendments also simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment for impairment quarterly at each reporting period. We adopted ASU 2016-01 during the quarter ended September 30, 2018 and elected to apply the practical expedient for measuring equity investments that do not have readily determinable fair market. Based on our elections, our strategic equity investments that do not have readily determinable fair values are measured at cost, less any impairments, plus or minus changes resulting from observable price changes in orderly transactions for identifiable or similar investments of the same issuer. The measurement alternative was applied prospectively and the adoption of ASU 2016-01 did not result in an adjustment to retained earnings.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory”

In October 2016, the FASB issued Accounting Standard Update ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory” (Topic 740). Under the new guidance, an entity is required to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs and eliminates the exception for an intra-entity transfer of an asset other than inventory. ASU 2016-16 became effective during the three months ended September 30, 2018 and is required to be adopted on a modified retrospective basis, with a cumulative-effect adjustment recorded directly to retained earnings for intra-entity transfers that occur before the adoption date. Accordingly, we recognized the following reclassifications upon adoption (in thousands):



Balance Sheet Caption	As reported balance June 30, 2018		Adoption of ASU 2016-16 Increase/(Decrease)		Revised balance July 1, 2018
Assets
Prepaid expenses and other current assets	$	124,634	$	(28,947)	$	95,687
Prepaid taxes and other non-current assets		273,710		(156,406)		117,304
Deferred income taxes		53,818		(3,445)		50,373
Equity
Retained Earnings		2,432,328		(188,798)		2,243,530

(2) Inventories

Inventories were comprised of the following at September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Raw materials	$	74,219	$	75,415
Work in progress		2,280		2,453
Finished goods		206,056		190,833
Total inventories	$	282,555	$	268,701

(3) Property, Plant and Equipment

Property, plant and equipment were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Machinery and equipment	$	242,079	$	239,671
Computer equipment		160,396		155,069
Furniture and fixtures		50,647		51,045
Vehicles		7,532		7,399
Clinical, demonstration and rental equipment		88,826		92,229
Leasehold improvements		32,437		32,169
Land		53,286		54,089
Buildings		226,602		229,193
		861,805		860,864
Accumulated depreciation and amortization		(479,983)		(474,314)
Property, plant and equipment, net	$	381,822	$	386,550

(4) Goodwill

Changes in the carrying amount of goodwill for three months ended September 30, 2018, and September 30, 2017, were as follows (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	1,068,944	$	1,064,874
Business acquisition		125,037		-
Foreign currency translation adjustments		(1,951)		7,424
Balance at the end of the period	$	1,192,030	$	1,072,298

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(5) Other Intangible Assets

Other intangible assets were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Developed/core product technology	$	229,533	$	205,149
Accumulated amortization		(122,505)		(115,237)
Developed/core product technology, net		107,028		89,912
Trade names		53,797		48,832
Accumulated amortization		(18,447)		(16,868)
Trade names, net		35,350		31,964
Non-compete agreements		3,255		3,288
Accumulated amortization		(2,366)		(2,283)
Non-compete agreements, net		889		1,005
Customer relationships		127,634		118,084
Accumulated amortization		(51,077)		(48,157)
Customer relationships, net		76,557		69,927
Patents		92,246		91,708
Accumulated amortization		(69,877)		(69,332)
Patents, net		22,369		22,376
Total other intangibles, net	$	242,193	$	215,184

Intangible assets consist of developed/core product technology, trade names, non-compete agreements, customer relationships, and patents, which we amortize over the estimated useful life of the assets, generally between two and fifteen years. There are no expected residual values related to these intangible assets. In-process research and development is amortized over the estimated useful life of the assets, once the research and development efforts are completed.

(6) Equity Investments

The aggregate carrying amount of our equity investments at September 30, 2018 and June 30, 2018, was $42.0 million and $41.2 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets.

The carrying amounts of our equity investments without readily determinable fair values are initially measured at cost and are assessed for impairment and observable price changes in orderly transactions for identifiable or similar investments of the same issuer. We estimate the fair value of our equity investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows. During the three months ended September 30, 2018 and 2017, we recognized $1.7 million and $1.0 million, respectively, of impairment losses related to our equity investments. We have determined, after the impairment charge, that the fair value of our remaining investments exceed their carrying values.

The following table shows a reconciliation of the changes in our equity investments during the three months ended September 30, 2018 and September 30, 2017 (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	41,226	$	38,324
Investments		2,467		3,225
Impairment of equity investments		(1,711)		(962)
Balance at the end of the period	$	41,982	$	40,587

(7) Income Taxes

In accordance with ASC 740 Income Taxes, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.

Our income tax returns are based on calculations and assumptions subject to audit by various tax authorities. In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws. We regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. Any final assessment resulting from tax audits may result in material changes to our past or future taxable income, tax payable or deferred tax assets, and may require us to pay penalties and interest that could materially adversely affect our financial results.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

In connection with the audit by the Australian Taxation Office (“ATO”) for the tax years 2009 to 2013, we received Notices of Amended Assessments in March 2018. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed or $75.9 million. We do not agree with the ATO’s assessments and continue to believe we are more likely than not to be successful in defending our position. At September 30, 2018, we have recorded a receivable in prepaid taxes and other non-current assets for the amount paid as we ultimately expect this will be refunded by the ATO. The ATO are performing a risk review and auditing tax years 2014 to 2017.

On December 22, 2017, the SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) directing taxpayers to consider the impact of the U.S. legislation as “provisional” when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, we recognized additional estimated income tax expense of $138.0 million during the year ended June 30, 2018 based on our best estimate and interpretation of the U.S. legislation. We are still accumulating data to finalize the underlying calculations, or in certain cases, the U.S. Treasury is expected to issue further guidance on the application of certain provisions of the U.S. legislation and recorded a further $0.5 million in income tax expense during three months ended September 30, 2018. In accordance with SAB 118, the estimated income tax expense is considered provisional and will be finalized before December 22, 2018.

(8) Product Warranties

Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, for the three months ended September 30, 2018 and September 30, 2017, are as follows (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	19,227	$	19,558
Warranty accruals for the period		3,948		3,802
Warranty costs incurred for the period		(3,589)		(3,677)
Foreign currency translation adjustments		(261)		273
Balance at the end of the period	$	19,325	$	19,956

(9) Debt

Debt at September 30, 2018 and June 30, 2018 consisted of the following (in thousands):



	September 30, 2018		June 30, 2018
Short-term debt	$	12,000	$	12,000
Deferred borrowing costs		(25)		(534)
Short-term debt, net		11,975		11,466
		-
Long-term debt	$	520,000	$	272,000
Deferred borrowing costs		(2,363)		(2,012)
Long-term debt, net	$	517,637	$	269,988
Total debt	$	529,612	$	281,454

Credit Facility

On October 31, 2013, we entered into a revolving credit agreement, as borrower, with lenders, including Union Bank, N.A., as administrative agent, joint lead arranger, swing line lender and letters of credit issuer, and HSBC Bank USA, National Association, as syndication agent and joint lead arranger, providing for a revolving credit facility of $700.0 million, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million. On April 4, 2016, in connection with our acquisition of Brightree, we entered into a first amendment to the revolving credit agreement to increase the size of the revolving credit facility from $700.0 million to $1.0 billion, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million, and to make other modifications to provide for the acquisition of Brightree. On January 9, 2017, we entered into a second amendment to our agreement with our existing lenders, including MUFG Union Bank, N.A. as successor in interest to Union Bank, N.A., as Administrative Agent, Joint Lead Arranger, Swing Line Lender and L/C Issuer; and HSBC Bank USA, National Association, as Syndication Agent and Joint Lead Arranger. The second amendment, among other things, increased the size of our senior unsecured revolving credit facility from $1.0 billion to $1.3 billion, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million. The credit facility was due to terminate on October 31, 2018, when all unpaid principal and interest under the loans were to be repaid.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

On April 17, 2018, we entered into an Amended and Restated Credit Agreement (the “Revolving Credit Agreement”), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger, joint book runner, swing line lender and letter of credit issuer, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner. The Revolving Credit Agreement, among other things, provides a senior unsecured revolving credit facility of $800.0 million, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million.

Additionally, on April 17, 2018, ResMed Limited entered into a Syndicated Facility Agreement (the “Term Credit Agreement”), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger and joint book runner, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner. The Term Credit Agreement, among other things, provides ResMed Limited a senior unsecured term credit facility of $200.0 million.

The Revolving Credit Agreement and Term Credit Agreement each terminate on April 17, 2023, when all unpaid principal and interest under the loans must be repaid. The term credit facility will also amortize on a semi-annual basis, with a $6.0 million principal payment required on each such semi-annual amortization date. The outstanding principal amounts will bear interest at a rate equal to LIBOR plus 0.75% to 1.50% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable) plus 0.0% to 0.50% (depending on the then-applicable leverage ratio).

Our obligations under the Revolving Credit Agreement and Term Credit Agreement are guaranteed by us and certain of our direct and indirect U.S. subsidiaries, including, in each case, ResMed Corp., ResMed Motor Technologies Inc., Birdie Inc., Inova Labs, Inc., Brightree LLC, Brightree Services LLC, Brightree Home Health & Hospice LLC, and Brightree Patient Collections LLC. The Revolving Credit Agreement and Term Credit Agreement contain customary covenants, including, in each case, a financial covenant that requires that we maintain a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement and Term Credit Agreement, as applicable). The entire principal amounts of the revolving credit facility and term credit facility, and, in each case, any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable. Events of default under the Revolving Credit Agreement and the Term Credit Agreement include, in each case, failure to make payments when due, the occurrence of a default in the performance of any covenants in the respective agreements or related documents, or certain changes of control of ResMed, the respective guarantors of the revolving credit facility and the term credit facility, ResMed Holdings Ltd and/or ResMed EAP Holdings LLC.

At September 30, 2018, the interest rate that was being charged on the outstanding principal amounts was 3.0%. An applicable commitment fee of 0.100% to 0.175% (depending on the then-applicable leverage ratio) applies on the unused portion of the revolving credit facility. At September 30, 2018, we were in compliance with our debt covenants and there was $529.6 million outstanding under the revolving credit facility and term credit facility.

(10) Stockholders’ Equity

Common Stock. During the three months ended September 30, 2018, we repurchased 200,000 shares at an aggregate purchase price of $22.8 million under our share repurchase program. Since the inception of our share repurchase programs and through September 30, 2018, we have repurchased a total of 41.8 million shares for an aggregate of $1.6 billion. Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. At September 30, 2018, 12.9 million additional shares can be repurchased under the approved share repurchase program.

Preferred Stock. In April 1997, the board of directors designated 2.0 million shares of our $0.01 par value preferred stock as Series A Junior Participating Preferred Stock. No shares were issued or outstanding at September 30, 2018 and June 30, 2018.

Stock Options and Restricted Stock Units. We have granted stock options and restricted stock units to personnel, including officers and directors, in accordance with the amended and restated ResMed Inc. 2009 Incentive Award Plan (as amended and restated, the “2009 Plan”). The options have expiration dates of seven years from the date of grant and the options and restricted stock units vest over one to four years.

At September 30, 2018, the maximum number of shares of our common stock authorized for issuance under the 2009 Plan was 51.1 million shares. The number of securities remaining available for future issuance under the 2009 Plan at September 30, 2018 was 17.8 million.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

The following table summarizes option activity during the three months ended September 30, 2018:



	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,205,826	$	60.48	4.4
Granted		-		-
Exercised		(11,973)		42.84
Forfeited		(183)		52.02
Outstanding at end of period		1,193,670	$	60.65	4.1
Exercise price of granted options	$	-
Options exercisable at end of period		671,647	$	52.43

The following table summarizes the activity of restricted stock units during the three months ended September 30, 2018:



	Restricted Stock Units		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,644,754	$	62.89	1.6
Granted		7,093		104.57
Vested		(2,911)		64.90
Expired / cancelled		(10,206)		63.80
Forfeited		(2,314)		63.80
Outstanding at end of period		1,636,416	$	63.08	1.4

Employee Stock Purchase Plan (the “ESPP”). Under the ESPP, we offer participants the right to purchase shares of our common stock at a discount during successive offering periods. At September 30, 2018, the number of shares remaining available for future issuance under the ESPP is 0.5 million shares.

(11) Earnings Per Share

Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units.

For the three months ended September 30, 2018 and September 30, 2017, stock options and restricted stock units covering an aggregate of 10,006 and 6,982 shares of common stock, respectively, were not included in the computation of diluted earnings per share as the effect would have been anti-dilutive.

Basic and diluted earnings per share for the three months ended September 30, 2018 and September 30, 2017 are calculated as follows (in thousands except per share data):



	Three Months Ended September 30,
	2018		2017
Numerator:
Net income	$	105,737	$	86,125
Denominator:
Basic weighted-average common shares outstanding		142,668		142,247
Effect of dilutive securities:
Stock options and restricted stock units		1,362		1,233
Diluted weighted average shares		144,030		143,480
Basic earnings per share	$	0.74	$	0.61
Diluted earnings per share	$	0.73	$	0.60

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(12) Fair Value Measurements

In determining the fair value measurements of our financial assets and liabilities, we consider the principal and most advantageous market in which we transact and consider assumptions that market participants would use when pricing the financial asset or liability. We maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The hierarchies of inputs are as follows:


	Level 1:	Input prices quoted in an active market for identical financial assets or liabilities;
	Level 2:	Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and
	Level 3	Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market.

The following table summarizes our financial assets and liabilities at September 30, 2018 and June 30, 2018, using the valuation input hierarchy (in thousands):



	Level 1		Level 2		Level 3		Total
Balances at September 30, 2018
Foreign currency hedging instruments, net	$	-	$	(587)	$	-	$	(587)
Business acquisition contingent consideration	$	-	$	-	$	(1,082)	$	(1,082)
Balances at June 30, 2018
Foreign currency hedging instruments, net	$	-	$	(2,699)	$	-	$	(2,699)
Business acquisition contingent consideration	$	-	$	-	$	(1,505)	$	(1,505)

We determine the fair value of our financial assets and liabilities as follows:

Foreign currency hedging instruments – These financial instruments are valued using third-party valuation models based on market observable inputs, including interest rate curves, on-market spot currency prices, volatilities and credit risk.

Contingent consideration – These liabilities include the fair value estimates of additional future payments that may be required for some of our previous business acquisitions based on the achievement of certain performance milestones. Each potential future payment is valued using the estimated probability of achieving each milestone, which is then discounted to present value.

The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2018 and September 30, 2017 (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	(1,505)	$	(1,580)
Changes in fair value included in operating income		183		-
Payments		240		-
Balance at the end of the period	$	(1,082)	$	(1,580)

We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2018 or June 30, 2018.

(13) Legal Actions and Contingencies

Litigation

In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Taxation Matters

As described in note 7 – Income Taxes, we received Notices of Amended Assessments from the ATO for the tax years 2009 to 2013. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed, or $75.9 million. We do not agree with the ATO’s assessments and we continue to believe we are more likely than not to be successful in defending our position. However, if we are not successful, we will not receive a refund of the $75.9 million paid in April 2018 and we would be required to pay the remaining $75.9 million in additional income tax, $38.4 million in accrued interest and $75.9 million in penalties, which would be recorded as income tax expense. The ATO are performing a risk review and auditing tax years 2014 to 2017.

In connection with the recent U.S. Tax Act and the analysis of historical tax filings, we identified an administrative oversight in our prior year tax filing relating to a gain on an internal legal entity reorganization. We have applied for relief from the U.S. Internal Revenue Service (“IRS”) to amend the related tax returns required to correct the administrative oversight, which would indefinitely defer the recognition of this gain. We believe it is more likely than not that we will be granted this relief and therefore, have not recorded a reserve in relation to this matter during the three months ended September 30, 2018. As of September 30, 2018, we were awaiting additional communication from the IRS regarding the amended tax returns.

Contingent Obligations Under Recourse Provisions

We use independent financing institutions to offer some of our customers financing for the purchase of some of our products. Under these arrangements, if the customer qualifies under the financing institutions’ credit criteria and finances the transaction, the customers repay the financing institution on a fixed payment plan. For some of these arrangements, the customer’s receivable balance is with recourse, either limited or full, whereby we are responsible for repaying the financing company should the customer default. We record a contingent provision, which is estimated based on historical default rates. This is applied to receivables sold with recourse and is recorded in accrued expenses.

The following table summarizes the amount of receivables sold with recourse during the three months ended September 30, 2018 and September 30, 2017(in thousands):



	Three Months Ended September 30,
	2018		2017
Total receivables sold:
Full recourse	$	10,082	$	4,200
Limited recourse		18,824		17,434
Total	$	28,906	$	21,634

The following table summarizes the maximum exposure on outstanding receivables sold with recourse and provision for doubtful accounts at September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Maximum exposure on outstanding receivables:
Full recourse	$	22,308	$	20,139
Limited recourse		10,190		9,239
Total	$	32,498	$	29,378

Contingent provision for receivables with recourse	$	(1,252)	$	(2,277)

(14) Derivative Instruments and Hedging Activities

We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through both our Australian and Singapore manufacturing activities, and international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The terms of such foreign currency hedging contracts generally do not exceed three years. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures denominated mainly in Euros, and Australian and Singapore dollars. Under this program, increases or decreases in our foreign currency denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

We do not designate these foreign currency contracts as hedges. We have determined our hedge program to be a non-effective hedge as defined under the FASB-issued authoritative guidance. All movements in the fair value of the foreign currency instruments are recorded within other income, net in our condensed consolidated statements of income. We do not enter into financial instruments for trading or speculative purposes.

We held foreign currency instruments with notional amounts totaling $530.2 million and $462.1 million at September 30, 2018 and June 30, 2018, respectively, to hedge foreign currency fluctuations. These contracts mature at various dates prior to December 31, 2019.

The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018		Balance Sheet Caption
Foreign currency hedging instruments	$	1,299	$	281	Other assets - current
Foreign currency hedging instruments		(1,352)		(2,373)	Accrued expenses
Foreign currency hedging instruments		(534)		(607)	Other long-term liabilities
	$	(587)	$	(2,699)

The following table summarizes the amount and location of gains (losses) associated with our derivative financial instruments for the three months ended September 30, 2018 and September 30, 2017, respectively (in thousands):



	Gain /(Loss) Recognized				Income Statement Caption
	Three Months Ended September 30,
	2018		2017
Foreign currency hedging instruments	$	(1,699)	$	1,646	Other, net
Other foreign-currency-denominated transactions		887		(2,282)	Other, net
	$	(812)	$	(636)

We are exposed to credit-related losses in the event of non-performance by counter parties to financial instruments. We minimize counterparty credit risk by entering into derivative transactions with major financial institutions and we do not expect material losses as a result of default by our counterparties.

(15) Business Combinations

On July 6, 2018 we completed the acquisition of 100% of the shares in Healthcarefirst Holding Company (“Healthcarefirst”), a provider of software solutions and services for home health and hospice agencies, for a total purchase consideration of $126.3 million.

This acquisition has been accounted for as a business combination using purchase accounting and is included in our consolidated financial statements from the acquisition date. The acquisition is not considered a material business combination and accordingly pro forma information is not provided. The acquisition was funded by drawing on our existing credit facility.

The purchase price allocation associated with the Healthcarefirst acquisition is preliminary and we expect to complete this by the quarter ending June 30, 2019. We do not believe that the completion of this work will materially modify the preliminary purchase price allocation for Healthcarefirst. The cost of the acquisition was allocated to the assets acquired and liabilities assumed based on estimates of their fair values at the date of acquisition. The goodwill recognized as part of this acquisition of $125.0 million, which is not deductible for tax purposes, mainly represents the synergies that are unique to our combined businesses and the potential for new products and services to be developed in the future.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

This report contains or may contain certain forward-looking statements and information that are based on the beliefs of our management as well as estimates and assumptions made by, and information currently available to, our management. All statements other than statements regarding historical facts are forward-looking statements. The words “believe,” “expect,” “intend,” “anticipate,” “will continue,” “will,” “estimate,” “plan,” “future” and other similar expressions, and negative statements of such expressions, generally identify forward-looking statements, including, in particular, statements regarding projections of future revenue or earnings, expenses, new product development, new product launches, new markets for our products, litigation, and tax outlook. These forward-looking statements are made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements reflect the views of our management at the time the statements are made and are subject to a number of risks, uncertainties, estimates and assumptions, including, without limitation, and in addition to those identified in the text surrounding such statements, those identified in our annual report on Form 10-K for the fiscal year ended June 30, 2018 and elsewhere in this report.

In addition, important factors to consider in evaluating such forward-looking statements include changes or developments in healthcare reform, social, economic, market, legal or regulatory circumstances, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors, the actions or omissions of third parties, including suppliers, customers, competitors and governmental authorities and various other factors. If any one or more of these risks or uncertainties materialize, or underlying estimates or assumptions prove incorrect, actual results may vary significantly from those expressed in our forward-looking statements, and there can be no assurance that the forward-looking statements contained in this report will in fact occur.

Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described in our annual report on Form 10-K for the fiscal year ended June 30, 2018, in addition to the other cautionary statements and risks described elsewhere in this report and in our other filings with the Securities and Exchange Commission (“SEC”), including our subsequent reports on Forms 10-Q and 8-K. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on us, our business, financial condition and results of operations could be seriously harmed. In that event, the market price for our common stock will likely decline and you may lose all or part of your investment.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

The following is an overview of our results of operations for the three months ended September 30, 2018. Management’s discussion and analysis of financial condition and results of operations is intended to help the reader understand the results of operations and financial condition of ResMed Inc. Management’s discussion and analysis is provided as a supplement to, and should be read in conjunction with, the condensed consolidated financial statements and notes included in this report.

We are a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (“SDB”), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Our products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. Our cloud-based software digital health applications, along with our devices are designed to provide connected care to improve patient outcomes and efficiencies for our customers.

Since the development of continuous positive airway pressure therapy, we have expanded our business by developing or acquiring a number of products and solutions for a broader range of respiratory disorders including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators and cloud-based software informatics solutions to manage patient outcomes and customer and provider business processes. Our growth has been fueled by geographic expansion, our research and product development efforts, acquisitions and an increasing awareness of SDB and respiratory conditions like chronic obstructive pulmonary disease as significant health concerns. During the three months ended September 30, 2018, we invested $38.8 million on research and development activities with a continued focus on the development and commercialization of new, innovative products and solutions that improve patient outcomes, create efficiencies for our customers and help physicians and providers better manage chronic disease and lower healthcare costs.

During the three months ended September 30, 2018, our net revenue increased by 12% compared to the three months ended September 30, 2017. Gross margin was 58.3% for the three months ended September 30, 2018 compared to 58.4% for the three months ended September 30, 2017. Diluted earnings per share for the three months ended September 30, 2018 was $0.73 per share, compared to $0.60 per share for the three months ended September 30, 2017.

At September 30, 2018, our cash and cash equivalents totaled $230.2 million, our total assets were $3.1 billion and our stockholders’ equity was $1.9 billion.

In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, we provide certain financial information on a “constant currency basis”, which is in addition to the actual financial information presented. In order to calculate our constant currency information, we translate the current period financial information using the foreign currency exchange rates that were in effect during the previous comparable period. However, constant currency measures should not be considered in isolation or as an alternative to U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Net Revenue

Net revenue for the three months ended September 30, 2018 increased to $588.3 million from $523.7 million for the three months ended September 30, 2017, an increase of $64.6 million or 12% (a 13% increase on a constant currency basis). The increase in net revenue was attributable to an increase in unit sales of our devices, masks and accessories, partially offset by a decline in average selling prices. Movements in international currencies against the U.S. dollar negatively impacted net revenues by approximately $4.8 million for the three months ended September 30, 2018. Revenue from our software as a service business, for the three months ended September 30, 2018 was $47.5 million, an increase of 25% over the prior year quarter, and includes revenue contributed by Healthcarefirst after we acquired it on July 6, 2018.

Net revenue in U.S., Canada and Latin America, excluding revenue attributable to our software as a service business, for the three months ended September 30, 2018 increased to $326.4 million from $296.6 million for the three months ended September 30, 2017, an increase of $29.8 million or 10%. The increase in net revenue in U.S., Canada and Latin America, excluding revenue attributable to our software as a service business, is primarily due to an increase in unit sales of our devices, masks and accessories, partially offset by a decline in average selling prices.

Net revenue in combined Europe, Asia and other markets increased for the three months ended September 30, 2018 to $214.4 million from $189.0 million for the three months ended September 30, 2017, an increase of $25.4 million or 13% (a 16% increase on a constant currency basis). The constant currency increase in sales in combined Europe, Asia and other markets predominantly reflects an increase in unit sales of our devices, masks and accessories, partially offset by a decline in average selling prices.

Net revenue from devices for the three months ended September 30, 2018 increased to $324.1 million from $286.2 million for the three months ended September 30, 2017, an increase of 13%, including an increase of 9% in U.S., Canada and Latin America and an increase of 18% in combined Europe, Asia and other markets (a 20% increase on a constant currency basis). Net revenue from masks and other accessories for the three months ended September 30, 2018 increased to $216.7 million from $199.4 million for the three months ended September 30, 2017, an increase of 9%, including an increase of 11% in U.S., Canada and Latin America and an increase of 3% in combined Europe, Asia and other markets (a 6% increase on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2018 increased by 14%, and masks and accessories sales increased by 10%, compared to the three months ended September 30, 2017.

The following table summarizes the percentage movements in our net revenue for the three months ended September 30, 2018 compared to the three months ended September 30, 2017:



	U.S., Canada and Latin America	Combined Europe, Asia and other markets	Total	Combined Europe, Asia and other markets (Constant Currency)*	Total (Constant Currency)*
Devices	9%	18%	13%	20%	14%
Masks and other accessories	11%	3%	9%	6%	10%
Total devices and masks	10%	13%	11%	16%	12%
Software as a Service	25%	-	25%	-	25%
Total	12%	13%	12%	16%	13%

*Constant currency numbers exclude the impact of movements in international currencies.

Gross Profit

Gross profit increased for the three months ended September 30, 2018 to $343.1 million from $305.6 million for the three months ended September 30, 2017, an increase of $37.5 million or 12%. Gross profit as a percentage of net revenue for the three months ended September 30, 2018 was 58.3% compared to 58.4% for the three months ended September 30, 2017. Our gross margin was lower than last year which was primarily due to declines in our average selling prices, largely offset by manufacturing and procurement efficiencies.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased for the three months ended September 30, 2018 to $147.3 million from $143.9 million for the three months ended September 30, 2017, an increase of $3.5 million or 2%. Selling, general and administrative expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $2.4 million, as reported in U.S. dollars. Excluding the impact of foreign currency movements, selling, general and administrative expenses for the three months ended September 30, 2018 increased by 4% compared to the three months ended September 30, 2017. Selling, general and administrative expenses, as a percentage of net revenue, were 25.0% for the three months ended September 30, 2018, compared to 27.5% for the three months ended September 30, 2017.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The constant currency increase in selling, general and administrative expenses was primarily due to increased legal expenses, increased professional service fees and additional expenses associated with acquisitions.

Research and Development Expenses

Research and development expenses increased for the three months ended September 30, 2018 to $38.8 million from $37.4 million for the three months ended September 30, 2017, an increase of $1.4 million, or 4%. Research and development expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $1.7 million for the three months ended September 30, 2018, as reported in U.S. dollars. Excluding the impact of foreign currency movements, research and development expenses increased by 8% compared to the three months ended September 30, 2017. Research and development expenses, as a percentage of net revenue, were 6.6% for the three months ended September 30, 2018, compared to 7.1% for the three months ended September 30, 2017.

The increase in research and development expenses in constant currency terms was primarily due to increases in materials and tooling costs incurred to facilitate development of new products.

Amortization of Acquired Intangible Assets

Amortization of acquired intangible assets for the three months ended September 30, 2018 totaled $12.9 million compared to $11.8 million for the three months ended September 30, 2017.

Total Other Income (Loss), Net

Total other (loss) income, net for the three months ended September 30, 2018 was a loss of $5.3 million compared to a loss of $4.1 million for the three months ended September 30, 2017. The increase was due primarily to the impairment of our equity investments of $1.7 million for the three months ended September 30, 2018 compared to the impairment of $1.0 million for the three months ended September 30, 2017.

Income Taxes

Our effective income tax rate for the three months ended September 30, 2018 was 23.9% as compared to 20.6% for the three months ended September 30, 2017.

In addition, our effective income tax rate was affected by the geographic mix of our earnings. Our Singapore and Malaysia operations operate under certain tax holidays and tax incentive programs that will expire in whole or in part at various dates through June 30, 2030. As a result of U.S. legislation, we treated all non-U.S. historical earnings as taxable during the year ended June 30, 2018. Therefore, future repatriation of cash held by our non-U.S. subsidiaries will generally not be subject to U.S. federal tax if repatriated.

Finally, in connection with the audit by the Australian Taxation Office (“ATO”) for the tax years 2009 to 2013, we received Notices of Amended Assessments in March 2018. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. At September 30, 2018, we have recorded a receivable in prepaid taxes and other non-current assets for the amount paid as we ultimately expect this will be refunded by the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed or $75.9 million. We do not agree with the ATO’s assessments and continue to believe we are more likely than not to be successful in defending our position. The ATO are performing a risk review and auditing tax years 2014 to 2017.

Net Income and Earnings per Share

As a result of the factors above, our net income for the three months ended September 30, 2018 was $105.7 million compared to net income of $86.1 million for the three months ended September 30, 2017, an increase of 23% over the three months ended September 30, 2017.

Our diluted earnings per share for the three months ended September 30, 2018 were $0.73 per diluted share compared to $0.60 for the three months ended September 30, 2017.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Liquidity and Capital Resources

As of September 30, 2018 and June 30, 2018, we had cash and cash equivalents of $230.2 million and $188.7 million, respectively. Working capital was $667.1 million and $554.5 million, at September 30, 2018 and June 30, 2018, respectively.

As of September 30, 2018 and June 30, 2018, our cash and cash equivalent balances held within the United States amounted to $27.5 million and $23.2 million, respectively. Our remaining cash and cash equivalent balances at September 30, 2018 and June 30, 2018, were $202.7 million and $165.5 million, respectively. Our cash and cash equivalent balances are held at highly rated financial institutions.

During the year ended June 30, 2018, as a result of U.S. legislation, we treated all non-U.S. historical earnings as taxable for U.S. federal tax purposes, which resulted in additional tax expense recorded of $125.5 million which is payable over the next eight years. Therefore, future repatriation of cash held by our non-U.S. subsidiaries will generally not be subject to U.S. federal tax if repatriated. As we evaluate the impact of U.S. tax legislation and the future cash needs of our global operations, we may revise the amount of foreign earnings considered to be permanently reinvested outside the United States.

Inventories at September 30, 2018 were $282.6 million, an increase of $13.9 million or 5% from the June 30, 2018 balance of $268.7 million. The increase in inventories was required to support our revenue growth.

Accounts receivable at September 30, 2018 were $463.7 million, a decrease of $19.9 million or 4% compared to the June 30, 2018, balance of $483.7 million. Accounts receivable days outstanding of 73 days at September 30, 2018, were higher than the 69 days at June 30, 2018. Our allowance for doubtful accounts as a percentage of total accounts receivable at September 30, 2018, was 4.5%, compared to 3.8% at June 30, 2018.

During the three months ended September 30, 2018, we generated cash of $48.1 million from operations compared to $94.0 million for the three months ended September 30, 2017. The lower level of cash generated from operations during the three months ended September 30, 2018, was primarily due to the increase in income tax payments which increased from $30.2 million during the three months ended September 30, 2017 to $125.0 million during the three months ended September 30, 2018. Movements in foreign currency exchange rates during the three months ended September 30, 2018, had the effect of decreasing our cash and cash equivalents by $3.3 million, as reported in U.S. dollars. During the three months ended September 30, 2018, we also repurchased 200,000 shares of our common stock at an aggregate purchase price of $22.8 million under our share repurchase program. We did not repurchase any shares during the three months ended September 30, 2017. In addition, during the three months ended September 30, 2018 and 2017, we paid dividends to holders of our common stock totaling $52.8 million and $49.7 million, respectively.

Capital expenditures for the three months ended September 30, 2018 and 2017, amounted to $13.0 million and $16.0 million, respectively. The capital expenditures for the three months ended September 30, 2018, primarily reflected investment in computer hardware and software, production tooling, equipment and machinery, and rental and loan equipment. At September 30, 2018, our balance sheet reflects net property, plant and equipment of $381.8 million compared to $386.6 million at June 30, 2018.

Contractual Obligations

Details of contractual obligations at September 30, 2018, are as follows (in thousands):



			Payments Due by September 30,
In $000’s	Total		2019		2020		2021		2022		2023		Thereafter
Short-term debt	$	12,000	$	12,000	$	-	$	-	$	-	$	-	$	-
Interest on short-term debt		5,797		5,797		-		-		-		-		-
Long-term debt		520,000		-		12,000		12,000		12,000		484,000		-
Interest on long-term debt		66,683		10,353		15,791		15,433		15,074		10,032		-
Operating leases		58,269		18,877		12,988		9,154		6,118		4,697		6,435
Capital leases		2		2		-		-		-		-		-
Purchase obligations		276,369		274,025		1,924		420		-		-		-
Total	$	939,120	$	321,054	$	42,703	$	37,007	$	33,192	$	498,729	$	6,435

Details of other commercial commitments at September 30, 2018, are as follows (in thousands):



			Amount of Commitment Expiration Per Period
In $000’s	Total		2019		2020		2021		2022		2023		Thereafter
Standby letter of credit	$	11,576	$	4,115	$	207	$	-	$	-	$	-	$	7,254
Guarantees*		8,012		42		130		1,275		13		19		6,533
Total	$	19,588	$	4,157	$	337	$	1,275	$	13	$	19	$	13,787

*The above guarantees mainly relate to requirements under contractual obligations with insurance companies transacting with our German subsidiaries and guarantees provided under our facility leasing obligations.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Credit Facility

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Common Stock

During the three months ended September 30, 2018, we repurchased 200,000 shares of our common stock at an aggregate purchase price of $22.8 million under our share repurchase program. We did not repurchase any shares during the three months ended September 30, 2017. Since the inception of our share repurchase programs and through September 30, 2018, we have repurchased a total of 41.8 million shares at a cost of $1.6 billion. Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. At September 30, 2018, 12.9 million additional shares can be repurchased under the approved share repurchase program.

Critical Accounting Principles and Estimates

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, including those related to allowance for doubtful accounts, inventory reserves, warranty obligations, goodwill, potentially impaired assets, intangible assets, income taxes and contingencies.

We state these accounting policies in the notes to the financial statements and at relevant sections in this discussion and analysis. The estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.

Refer to the “Revenue Recognition” section at note 1 – Significant Accounting Policies where we have outlined our new policy following the adoption of Accounting Standard Codification Topic 606 – Contracts with Customers during the current quarter. All other critical accounting policies have remained unchanged. For a full discussion of our critical accounting policies, see our Annual Report on Form 10-K for the year ended June 30, 2018.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Recently Issued Accounting Pronouncements

See note 1 to the unaudited condensed consolidated financial statements for a description of recently issued accounting pronouncements, including the expected dates of adoption and estimated effects on our results of operations, financial positions and cash flows.

Off-Balance Sheet Arrangements

As of September 30, 2018, we are not involved in any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated by the SEC.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 3

RESMED INC. AND SUBSIDIARIES

Quantitative and Qualitative Disclosures About Market Risk

Foreign Currency Market Risk

Our reporting currency is the U.S. dollar, although the financial statements of our non-U.S. subsidiaries are maintained in their respective local currencies. We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollar. We have significant foreign currency exposure through our Australian and Singapore manufacturing activities and our international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures predominantly denominated in euros, Australian dollars and Singapore dollars. Under this program, increases or decreases in our foreign-currency-denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments. We do not enter into financial instruments for trading or speculative purposes. The foreign currency derivatives portfolio is recorded in the condensed consolidated balance sheets at fair value and included in other assets or other liabilities. All movements in the fair value of the foreign currency derivatives are recorded within other income, net, on our condensed consolidated statements of income.

The table below provides information (in U.S. dollars) on our significant foreign-currency-denominated balances by legal entity functional currency as of September 30, 2018 (in thousands):



	U.S.		Canadian	Chinese
	Dollar	Euro	Dollar	Yuan
	(USD)	(EUR)	(CAD)	(CNY)
AUD Functional:
Assets	253,191	137,579	-	21,413
Liability	(224,488)	(94,715)	-	(662)
Foreign Currency Hedges	(25,000)	(56,892)	-	(17,473)
Net Total	3,703	(14,028)	-	3,278
USD Functional:
Assets	-	-	20,099	-
Liability	-	(19)	(1,331)	-
Foreign Currency Hedges	-	-	(15,503)	-
Net Total	-	(19)	3,265	-
SGD Functional:
Assets	297,553	146,314	-	844
Liability	(76,692)	(44,839)	-	(23)
Foreign Currency Hedges	(233,000)	(101,012)	-	-
Net Total	(12,139)	463	-	821

Table of Contents


PART I – FINANCIAL INFORMATION	Item 3

RESMED INC. AND SUBSIDIARIES

Quantitative and Qualitative Disclosures About Market Risk

The table below provides information about our material foreign currency derivative financial instruments and presents the information in U.S. dollar equivalents. The table summarizes information on instruments and transactions that are sensitive to foreign currency exchange rates, including foreign currency call options, collars and forward contracts held at September 30, 2018. The table presents the notional amounts and weighted average exchange rates by contractual maturity dates for our foreign currency derivative financial instruments, including the forward contracts used to hedge our foreign currency denominated assets and liabilities. These notional amounts generally are used to calculate payments to be exchanged under the contracts (in thousands, except exchange rates).



				Fair Value Assets / (Liabilities)
Foreign Exchange Contracts	Year 1	Year 2	Total	September 30, 2018	June 30, 2018
AUD/USD
Contract amount	25,000	-	25,000	(132)	(140)
Ave. contractual exchange rate	AUD 1 = USD 0.7263		AUD 1 = USD 0.7263
AUD/Euro
Contract amount	103,334	34,832	138,166	(963)	(1,286)
Ave. contractual exchange rate	AUD 1 = Euro 0.6389	AUD 1 = Euro 0.6488	AUD 1 = Euro 0.6413
SGD/Euro
Contract amount	101,012	-	101,012	730	(939)
Ave. contractual exchange rate	SGD 1 = Euro 0.6237		SGD 1 = Euro 0.6237
SGD/USD
Contract amount	233,000	-	233,000	102	(309)
Ave. contractual exchange rate	SGD 1 = USD 0.7321		SGD 1 = USD 0.7321
AUD/CNY
Contract amount	17,473	-	17,473	(33)	(17)
Ave. contractual exchange rate	AUD 1 = CNY 5.0135		AUD 1 = CNY 5.0135
USD/CAD
Contract amount	15,503	-	15,503	(291)	(8)
Ave. contractual exchange rate	USD 1 = CAD 1.3148		USD 1 = CAD 1.3148

Interest Rate Risk

We are exposed to risk associated with changes in interest rates affecting the return on our cash and cash equivalents and debt. At September 30, 2018, we held cash and cash equivalents of $230.2 million principally comprised of bank term deposits and at-call accounts and are invested at both short-term fixed interest rates and variable interest rates. At September 30, 2018, there was $529.6 million outstanding under the revolving credit facility, which was subject to variable interest rates. A hypothetical 10% change in interest rates during the three months ended September 30, 2018, would not have had a material impact on pretax income. We have no interest rate hedging agreements.

Table of Contents


PART I – FINANCIAL INFORMATION	Item 4

RESMED INC. AND SUBSIDIARIES

Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports made pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance management necessarily was required to apply its judgment in evaluating the cost benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2018.

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents


PART II – OTHER INFORMATION	Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 1 Legal Proceedings

We are involved in various legal proceedings, claims, investigations and litigation that arise in the ordinary course of our business. We investigate these matters as they arise, and accrue estimates for resolution of legal and other contingencies in accordance with Statement of Financial Accounting Standard No. 5. See note 13 to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

Litigation is inherently uncertain. Accordingly, we cannot predict with certainty the outcome of these matters. But we do not expect the outcome of these matters to have a material adverse effect on our consolidated financial statements when taken as a whole.

Fisher & Paykel Healthcare patent litigation. ResMed and Fisher & Paykel Healthcare are engaged in patent disputes in several global forums. ResMed and Fisher & Paykel have also filed proceedings in patent offices in the United States, Germany and Europe to invalidate many of the patents being asserted against that party.

Court cases related to the disputes are now pending in the United States (two cases filed August 2016 and August 2018, respectively in the Southern District of California—both cases have been stayed by the court), New Zealand (filed August 2016 in the High Court of New Zealand), Germany (filed on various dates in 2016 and 2017 in the District Court in Munich), and Australia (filed December 2017 in the Federal Court in Victoria).

In August and September 2018 each of ResMed and Fisher & Paykel filed petitions in the United States International Trade Commission seeking exclusion of allegedly infringing products by the other. ResMed is seeking exclusion of Fisher & Paykel’s Simplus, Eson and Eson 2 masks; Fisher & Paykel is seeking exclusion of ResMed’s P10 masks. The hearing for ResMed’s case against Fisher & Paykel is May 1, 2019, and the scheduled date for a decision by the International Trade Commission is March 4, 2020. The schedule for Fisher & Paykel’s International Trade Commission case against ResMed has not yet been established.

On October 18, 2018, the district court in Germany issued a judgment of infringement against headgear used on Fisher & Paykel’s Simplus and Eson 2 masks. Other cases will be set for trial in Germany on various dates in 2019 to be determined. The opening portion of the Australian trial against ResMed is set for April 23, 2019 (with the closing portion to be set on a later date to be determined) and the New Zealand trial against Fisher & Paykel is set for July 8, 2019.

We believe that the claims we are asserting against Fisher & Paykel are strong, and that we have strong defenses to the claims Fisher & Paykel is asserting against us. However, the claims asserted against us could cause us to incur significant expenses and, if successfully asserted against us, could require that we pay substantial damages or ongoing royalty payments, prevent us from selling certain of our products, or require that we comply with other unfavorable terms. We may also be obligated to pay substantial settlement costs, including royalty payments, in connection with these claims or litigation and to obtain licenses or modify products, which could be costly. Even if we were to prevail in these disputes, litigation regarding our intellectual property could be costly and time consuming and divert the attention of our management and key personnel from our business operations.

Administrative subpoenas. In 2016, we received federal administrative subpoenas from the Office of Inspector General of the U.S. Department of Health and Human Services. The subpoenas requested documents and other materials related primarily to industry offerings of patient resupply software to home medical equipment providers, discounted sales and leasing to sleep labs, samples, and other promotional programs. In addition, the government has informally requested information about our leasing arrangements with customers. In August 2018, we received a third subpoena, requesting documents and other materials relating to diagnostic devices and masks provided to medical providers, and diagnostic auto-scoring functions. We are cooperating with the government’s requests for documents and information. Responding to these investigations can consume substantial time and resources and can divert management’s attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may face litigation or have to agree to settlements that can include monetary penalties and onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business. If our operations are found to violate federal law or regulations, we may be subject to penalties, including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental health care programs, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results.

Item 1A Risk Factors

The discussion of our business and operations should be read together with the risk factors contained in our annual report on Form 10-K for the fiscal year ended June 30, 2018 which was filed with the SEC and describe the various risks and uncertainties to which we are or may become subject. As of September 30, 2018, there have been no further material changes to such risk factors.

Table of Contents


PART II – OTHER INFORMATION	Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 2 Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of equity securities. The following table summarizes purchases by us of our common stock during the three months ended September 30, 2018:



Period	Total Number of Shares Purchased		Average Price Paid per Share (USD)		Total Number of Shares Purchased as Part of Publicly Announced Programs (1)		Maximum Number of Shares that May Yet Be Purchased Under the Programs (1)
July 1 - 31, 2018		-		-		41,636,234		13,079,779
August 1 - 31, 2018		-		-		41,636,234		13,079,779
September 1 - 30, 2018		200,000	$	114.20		41,836,234		12,879,779
Total		200,000	$	114.20		41,836,234		12,879,779

(1) On February 21, 2014, our board of directors approved our current share repurchase program, authorizing us to acquire up to an aggregate of 20.0 million shares of our common stock. The program allows us to repurchase shares of our common stock from time to time for cash in the open market, or in negotiated or block transactions, as market and business conditions warrant and subject to applicable legal requirements. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. All share repurchases after February 21, 2014 have been executed under this program.

Item 3 Defaults Upon Senior Securities

None

Item 4 Mine Safety Disclosures

None

Item 5 Other Information

None

Table of Contents


PART II – OTHER INFORMATION	Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 6 Exhibits

Exhibits (numbered in accordance with Item 601 of Regulation S-K)


	3.1		First Restated Certificate of Incorporation of ResMed Inc., as amended. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Report on Form 10-Q for the quarter ended September 30, 2013)

	3.2		Fifth Amended and Restated Bylaws of ResMed Inc. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K/A filed on September 17, 2012)

	31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

	31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

	32		Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

	101		The following financial statements from ResMed Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, filed on October 25, 2018, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) the Notes to the Condensed Consolidated Financial Statements.

Table of Contents


PART II – OTHER INFORMATION	Signatures

RESMED INC. AND SUBSIDIARIES

Signatures

We have authorized the persons whose signatures appear below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

October 25, 2018

ResMed Inc.


/s/ MICHAEL J. FARRELL
Michael J. Farrell
Chief executive officer
(Principal Executive Officer)


/s/ BRETT A. SANDERCOCK
Brett A. Sandercock
Chief financial officer
(Principal Financial Officer)

EX-31.1 2 rmd-20180930xex31_1.htm EX-31.1 Exhibit 311 Q1 FY19


		Exhibit 31.1

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael J. Farrell, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of ResMed Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


	(b)	Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 25, 2018

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief executive officer

(Principal Executive Officer)

EX-31.2 3 rmd-20180930xex31_2.htm EX-31.2 Exhibit 312 Q1 FY19


		Exhibit 31.2

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brett A. Sandercock, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of ResMed Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)


	(b)	Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 25, 2018

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief financial officer

(Principal Financial Officer)

EX-32 4 rmd-20180930xex32.htm EX-32 Exhibit 32 Q1 FY19


		Exhibit 32

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ResMed Inc., a Delaware corporation (the “Company”), hereby certifies, to his knowledge, that:


(i)	the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and


(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 25, 2018

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief executive officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to ResMed Inc. and will be retained by ResMed Inc. and furnished to the Securities and Exchange Commission or its staff upon request. These certifications will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor will these certifications be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference.

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


(i)	the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 25, 2018

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief financial officer

(Principal Financial Officer)

EX-101.INS 5 rmd-20180930.xml EX-101.INS 0000943819 2017-07-01 2018-06-30 0000943819 rmd:EmployeeStockPurchasePlanMember 2018-09-30 0000943819 rmd:ResmedInc2009IncentiveAwardPlanMember 2018-09-30 0000943819 rmd:ResmedInc2009IncentiveAwardPlanMember 2018-07-01 2018-09-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2018-06-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2018-09-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2018-06-30 0000943819 srt:MinimumMember rmd:ResmedInc2009IncentiveAwardPlanMember 2018-07-01 2018-09-30 0000943819 srt:MaximumMember rmd:ResmedInc2009IncentiveAwardPlanMember 2018-07-01 2018-09-30 0000943819 rmd:SoftwareAsServiceMember rmd:UsCanadaAndLatinAmericaMember 2018-07-01 2018-09-30 0000943819 rmd:SoftwareAsServiceMember rmd:GlobalMember 2018-07-01 2018-09-30 0000943819 rmd:MasksMember rmd:UsCanadaAndLatinAmericaMember 2018-07-01 2018-09-30 0000943819 rmd:MasksMember rmd:GlobalMember 2018-07-01 2018-09-30 0000943819 rmd:MasksMember rmd:CombinedEuropeAsiaAndOtherMarketsMember 2018-07-01 2018-09-30 0000943819 rmd:DevicesMember rmd:UsCanadaAndLatinAmericaMember 2018-07-01 2018-09-30 0000943819 rmd:DevicesMember rmd:GlobalMember 2018-07-01 2018-09-30 0000943819 rmd:DevicesMember rmd:CombinedEuropeAsiaAndOtherMarketsMember 2018-07-01 2018-09-30 0000943819 rmd:DevicesAndMasksMember rmd:UsCanadaAndLatinAmericaMember 2018-07-01 2018-09-30 0000943819 rmd:DevicesAndMasksMember rmd:GlobalMember 2018-07-01 2018-09-30 0000943819 rmd:UsCanadaAndLatinAmericaMember 2018-07-01 2018-09-30 0000943819 rmd:GlobalMember 2018-07-01 2018-09-30 0000943819 rmd:CombinedEuropeAsiaAndOtherMarketsMember 2018-07-01 2018-09-30 0000943819 rmd:SoftwareAsServiceMember rmd:UsCanadaAndLatinAmericaMember 2017-07-01 2017-09-30 0000943819 rmd:SoftwareAsServiceMember rmd:GlobalMember 2017-07-01 2017-09-30 0000943819 rmd:MasksMember rmd:UsCanadaAndLatinAmericaMember 2017-07-01 2017-09-30 0000943819 rmd:MasksMember rmd:GlobalMember 2017-07-01 2017-09-30 0000943819 rmd:MasksMember rmd:CombinedEuropeAsiaAndOtherMarketsMember 2017-07-01 2017-09-30 0000943819 rmd:DevicesMember rmd:UsCanadaAndLatinAmericaMember 2017-07-01 2017-09-30 0000943819 rmd:DevicesMember rmd:GlobalMember 2017-07-01 2017-09-30 0000943819 rmd:DevicesMember rmd:CombinedEuropeAsiaAndOtherMarketsMember 2017-07-01 2017-09-30 0000943819 rmd:DevicesAndMasksMember rmd:UsCanadaAndLatinAmericaMember 2017-07-01 2017-09-30 0000943819 rmd:DevicesAndMasksMember rmd:GlobalMember 2017-07-01 2017-09-30 0000943819 rmd:UsCanadaAndLatinAmericaMember 2017-07-01 2017-09-30 0000943819 rmd:GlobalMember 2017-07-01 2017-09-30 0000943819 rmd:CombinedEuropeAsiaAndOtherMarketsMember 2017-07-01 2017-09-30 0000943819 us-gaap:VehiclesMember 2018-09-30 0000943819 us-gaap:MachineryAndEquipmentMember 2018-09-30 0000943819 us-gaap:LeaseholdImprovementsMember 2018-09-30 0000943819 us-gaap:LandMember 2018-09-30 0000943819 us-gaap:FurnitureAndFixturesMember 2018-09-30 0000943819 us-gaap:ComputerEquipmentMember 2018-09-30 0000943819 us-gaap:BuildingMember 2018-09-30 0000943819 rmd:ClinicalDemonstrationAndRentalEquipmentMember 2018-09-30 0000943819 us-gaap:VehiclesMember 2018-06-30 0000943819 us-gaap:MachineryAndEquipmentMember 2018-06-30 0000943819 us-gaap:LeaseholdImprovementsMember 2018-06-30 0000943819 us-gaap:LandMember 2018-06-30 0000943819 us-gaap:FurnitureAndFixturesMember 2018-06-30 0000943819 us-gaap:ComputerEquipmentMember 2018-06-30 0000943819 us-gaap:BuildingMember 2018-06-30 0000943819 rmd:ClinicalDemonstrationAndRentalEquipmentMember 2018-06-30 0000943819 us-gaap:SeriesAPreferredStockMember 2018-09-30 0000943819 us-gaap:SeriesAPreferredStockMember 2018-06-30 0000943819 us-gaap:SeriesAPreferredStockMember 1997-04-30 0000943819 rmd:ResmedLimitedMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-04-17 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-04-17 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankMember 2017-01-09 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2016-04-04 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2013-10-31 0000943819 rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-07-01 2018-09-30 0000943819 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-07-01 2018-09-30 0000943819 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-07-01 2018-09-30 0000943819 srt:MinimumMember us-gaap:AustralianTaxationOfficeMember 2018-07-01 2018-09-30 0000943819 srt:MaximumMember us-gaap:AustralianTaxationOfficeMember 2018-07-01 2018-09-30 0000943819 srt:MinimumMember us-gaap:AustralianTaxationOfficeMember 2018-03-01 2018-03-31 0000943819 srt:MaximumMember us-gaap:AustralianTaxationOfficeMember 2018-03-01 2018-03-31 0000943819 us-gaap:AustralianTaxationOfficeMember 2018-03-31 0000943819 us-gaap:AustralianTaxationOfficeMember 2018-03-01 2018-03-31 0000943819 rmd:LimitedRecourseMember 2018-09-30 0000943819 rmd:FullRecourseMember 2018-09-30 0000943819 rmd:LimitedRecourseMember 2018-06-30 0000943819 rmd:FullRecourseMember 2018-06-30 0000943819 us-gaap:NondesignatedMember 2018-07-01 2018-09-30 0000943819 us-gaap:NondesignatedMember 2017-07-01 2017-09-30 0000943819 us-gaap:TradeNamesMember 2018-09-30 0000943819 us-gaap:PatentsMember 2018-09-30 0000943819 us-gaap:CustomerRelationshipsMember 2018-09-30 0000943819 rmd:IntangiblesAndNonCompeteAgreementsMember 2018-09-30 0000943819 rmd:DevelopedOrCoreProductTechnologyMember 2018-09-30 0000943819 us-gaap:TradeNamesMember 2018-06-30 0000943819 us-gaap:PatentsMember 2018-06-30 0000943819 us-gaap:CustomerRelationshipsMember 2018-06-30 0000943819 rmd:IntangiblesAndNonCompeteAgreementsMember 2018-06-30 0000943819 rmd:DevelopedOrCoreProductTechnologyMember 2018-06-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2018-07-01 2018-09-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2017-07-01 2017-09-30 0000943819 us-gaap:ForeignExchangeContractMember 2018-07-01 2018-09-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-09-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-06-30 0000943819 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-09-30 0000943819 rmd:AccruedExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-09-30 0000943819 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-06-30 0000943819 rmd:AccruedExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-06-30 0000943819 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-09-30 0000943819 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-06-30 0000943819 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201616Member 2018-07-01 0000943819 rmd:RestatementRevisedMember 2018-07-01 0000943819 srt:ScenarioPreviouslyReportedMember 2018-06-30 0000943819 rmd:RevolvingCreditFacilityAndTermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-09-30 0000943819 rmd:ResmedLimitedMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-07-01 2018-09-30 0000943819 rmd:ResmedLimitedMember srt:MinimumMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2018-09-30 0000943819 rmd:ResmedLimitedMember srt:MinimumMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember us-gaap:BaseRateMember 2018-07-01 2018-09-30 0000943819 rmd:ResmedLimitedMember srt:MaximumMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-07-01 2018-09-30 0000943819 rmd:ResmedLimitedMember srt:MaximumMember rmd:TermLoanCreditAgreementMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember us-gaap:BaseRateMember 2018-07-01 2018-09-30 0000943819 us-gaap:ScenarioPlanMember us-gaap:TaxYear2018Member 2018-07-01 2018-09-30 0000943819 us-gaap:ScenarioPlanMember us-gaap:TaxYear2018Member 2017-07-01 2018-06-30 0000943819 rmd:DeferredRevenueNonCurrentLiabilitiesMember 2018-09-30 0000943819 rmd:DeferredRevenueNonCurrentLiabilitiesMember 2018-06-30 0000943819 rmd:DeferredRevenueCurrentLiabilitiesMember 2018-09-30 0000943819 rmd:DeferredRevenueCurrentLiabilitiesMember 2018-06-30 0000943819 rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember 2018-09-30 0000943819 rmd:PrepaidTaxesAndOtherNonCurrentAssetsMember 2018-06-30 0000943819 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2018-09-30 0000943819 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2018-06-30 0000943819 2017-09-30 0000943819 2017-06-30 0000943819 us-gaap:FairValueInputsLevel3Member 2018-09-30 0000943819 us-gaap:FairValueInputsLevel2Member 2018-09-30 0000943819 us-gaap:FairValueInputsLevel1Member 2018-09-30 0000943819 us-gaap:FairValueInputsLevel3Member 2018-06-30 0000943819 us-gaap:FairValueInputsLevel2Member 2018-06-30 0000943819 us-gaap:FairValueInputsLevel1Member 2018-06-30 0000943819 rmd:HealthcarefirstHoldingCompanyMember 2018-07-06 2018-07-06 0000943819 rmd:HealthcarefirstHoldingCompanyMember 2018-07-01 2018-09-30 0000943819 us-gaap:AustralianTaxationOfficeMember 2018-04-30 0000943819 rmd:AccountsReceivableNetMember 2018-09-30 0000943819 rmd:AccountsReceivableNetMember 2018-06-30 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankNaAndWestpacBankingCorporationMember 2018-04-17 2018-04-17 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:MufgUnionBankMember 2017-01-09 2017-01-09 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2016-04-04 2016-04-04 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2013-10-31 2013-10-31 0000943819 srt:MinimumMember 2018-07-01 2018-09-30 0000943819 srt:MaximumMember 2018-07-01 2018-09-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0000943819 rmd:LimitedRecourseMember 2018-07-01 2018-09-30 0000943819 rmd:FullRecourseMember 2018-07-01 2018-09-30 0000943819 rmd:LimitedRecourseMember 2017-07-01 2017-09-30 0000943819 rmd:FullRecourseMember 2017-07-01 2017-09-30 0000943819 2018-09-30 0000943819 2018-06-30 0000943819 us-gaap:AustralianTaxationOfficeMember 2018-06-01 2018-06-30 0000943819 rmd:OtherForeignCurrencyDenominatedTransactionsMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2018-07-01 2018-09-30 0000943819 rmd:OtherForeignCurrencyDenominatedTransactionsMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2017-07-01 2017-09-30 0000943819 rmd:HealthcarefirstHoldingCompanyMember 2018-07-06 0000943819 2017-07-01 2017-09-30 0000943819 2018-10-22 0000943819 2018-07-01 2018-09-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --06-30 Q1 2019 2018-09-30 10-Q 0000943819 142499749 false Large Accelerated Filer RESMED INC false rmd 11783000 12867000 125000000 240000 -2282000 887000 0.50 <div> <div style="margin-left:0pt;margin-right:0pt;"> Organization and Basis of Presentation ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group.  Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea.  Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States.  Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Norway and Sweden. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods.  The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2019. The condensed consolidated financial statements for the three months ended September 30, 2018 and September 30, 2017 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2018. </div> </div> 2277000 1252000 21634000 4200000 17434000 28906000 10082000 18824000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total receivables sold: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Full recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">10,082  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">4,200  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Limited recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">18,824  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">17,434  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">28,906  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">21,634  </td> </tr> </table></div> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Maximum exposure on outstanding receivables: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Full recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,308  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">20,139  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Limited recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">10,190  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">9,239  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">32,498  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">29,378  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contingent provision for receivables with recourse </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,252) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,277) </td> </tr> </table></div> </div> </div> 10206 63.80 12000000 12000000 P5Y P1Y 300000000 300000000 300000000 300000000

92723000

98709000

483681000

463743000

75900000

160427000

76137000

138102000

185805000

169465000

474314000

479983000

-224328000

-237200000

1450821000

1463669000

19258000

21928000

6982

10006

3063923000

3067538000

1065717000

1088243000

1998206000

1979295000

2018-07-06

1.00

126300000

-183000

1505000

1082000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (15)      Business Combinations On July 6, 2018 we completed the acquisition of 100% of the shares in Healthcarefirst Holding Company (“Healthcarefirst”), a provider of software solutions and services for home health and hospice agencies, for a total purchase consideration of $126.3 million. This acquisition has been accounted for as a business combination using purchase accounting and is included in our consolidated financial statements from the acquisition date. The acquisition is not considered a material business combination and accordingly pro forma information is not provided.  The acquisition was funded by drawing on our existing credit facility.  The purchase price allocation associated with the Healthcarefirst acquisition is preliminary and we expect to complete this by the quarter ending June 30, 2019. We do not believe that the completion of this work will materially modify the preliminary purchase price allocation for Healthcarefirst. The cost of the acquisition was allocated to the assets acquired and liabilities assumed based on estimates of their fair values at the date of acquisition. The goodwill recognized as part of this acquisition of $125.0 million, which is not deductible for tax purposes, mainly represents the synergies that are unique to our combined businesses and the potential for new products and services to be developed in the future.   </div> </div>

821935000

811102000

188701000

230188000

-10833000

41487000

0.35

0.37

0.004

350000000

184315866

184330350

142679632

142494116

571000

570000

122514000

92865000

13342000

12861000

2973000

3718000

60828000

64822000

71596000

73810000

218054000

245186000

138000000

500000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (9)      Debt Debt at September 30, 2018 and June 30, 2018 consisted of the following (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Short-term debt </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">12,000  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">12,000  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Deferred borrowing costs </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(25) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(534) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Short-term debt, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">11,975  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">11,466  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Long-term debt </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">520,000  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">272,000  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Deferred borrowing costs </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,363) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,012) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Long-term debt, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">517,637  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">269,988  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total debt </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">529,612  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">281,454  </td> </tr> </table></div> Credit Facility On October 31, 2013, we entered into a revolving credit agreement, as borrower, with lenders, including Union Bank, N.A., as administrative agent, joint lead arranger, swing line lender and letters of credit issuer, and HSBC Bank USA, National Association, as syndication agent and joint lead arranger, providing for a revolving credit facility of $700.0 million, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million. On April 4, 2016, in connection with our acquisition of Brightree, we entered into a first amendment to the revolving credit agreement to increase the size of the revolving credit facility from $700.0 million to $1.0 billion, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million, and to make other modifications to provide for the acquisition of Brightree. On January 9, 2017, we entered into a second amendment to our agreement with our existing lenders, including MUFG Union Bank, N.A. as successor in interest to Union Bank, N.A., as Administrative Agent, Joint Lead Arranger, Swing Line Lender and L/C Issuer; and HSBC Bank USA, National Association, as Syndication Agent and Joint Lead Arranger. The second amendment, among other things, increased the size of our senior unsecured revolving credit facility from $1.0 billion to $1.3 billion, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million. The credit facility was due to terminate on October 31, 2018, when all unpaid principal and interest under the loans were to be repaid. On April 17, 2018, we entered into an Amended and Restated Credit Agreement (the “Revolving Credit Agreement”), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger, joint book runner, swing line lender and letter of credit issuer, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner. The Revolving Credit Agreement, among other things, provides a senior unsecured revolving credit facility of $800.0 million, with an uncommitted option to increase the revolving credit facility by an additional $300.0 million.   Additionally, on April 17, 2018, ResMed Limited entered into a Syndicated Facility Agreement (the “Term Credit Agreement”), as borrower, with lenders MUFG Union Bank, N.A., as administrative agent, joint lead arranger and joint book runner, and Westpac Banking Corporation, as syndication agent, joint lead arranger and joint book runner. The Term Credit Agreement, among other things, provides ResMed Limited a senior unsecured term credit facility of $200.0 million.  The Revolving Credit Agreement and Term Credit Agreement each terminate on April 17, 2023, when all unpaid principal and interest under the loans must be repaid. The term credit facility will also amortize on a semi-annual basis, with a $6.0 million principal payment required on each such semi-annual amortization date. The outstanding principal amounts will bear interest at a rate equal to LIBOR plus 0.75% to 1.50% (depending on the then-applicable leverage ratio) or the Base Rate (as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable) plus 0.0% to 0.50% (depending on the then-applicable leverage ratio). Our obligations under the Revolving Credit Agreement and Term Credit Agreement are guaranteed by us and certain of our direct and indirect U.S. subsidiaries, including, in each case, ResMed Corp., ResMed Motor Technologies Inc., Birdie Inc., Inova Labs, Inc., Brightree LLC, Brightree Services LLC, Brightree Home Health & Hospice LLC, and Brightree Patient Collections LLC.  The Revolving Credit Agreement and Term Credit Agreement contain customary covenants, including, in each case, a financial covenant that requires that we maintain a maximum leverage ratio of funded debt to EBITDA (as defined in the Revolving Credit Agreement and Term Credit Agreement, as applicable). The entire principal amounts of the revolving credit facility and term credit facility, and, in each case, any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the Revolving Credit Agreement and the Term Credit Agreement, as applicable. Events of default under the Revolving Credit Agreement and the Term Credit Agreement include, in each case, failure to make payments when due, the occurrence of a default in the performance of any covenants in the respective agreements or related documents, or certain changes of control of ResMed, the respective guarantors of the revolving credit facility and the term credit facility, ResMed Holdings Ltd and/or ResMed EAP Holdings LLC. At September 30, 2018, the interest rate that was being charged on the outstanding principal amounts was 3.0%.  An applicable commitment fee of 0.100% to 0.175% (depending on the then-applicable leverage ratio) applies on the unused portion of the revolving credit facility. At September 30, 2018, we were in compliance with our debt covenants and there was $529.6 million outstanding under the revolving credit facility and term credit facility.   </div> </div>

0.0050

0.0150

0.000

0.0075

272000000

520000000

semi-annual

0.030

281454000

529612000

529600000

534000

25000

2012000

2363000

53818000

50373000

-3445000

46226000

13084000

16091000

29571000

30424000

462100000

530200000

281000

1299000

2373000

607000

1352000

534000

2699000

587000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (14)      Derivative Instruments and Hedging Activities We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through both our Australian and Singapore manufacturing activities, and international sales operations.  We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows.  The terms of such foreign currency hedging contracts generally do not exceed three years.  The goal of this hedging program is to economically manage the financial impact of foreign currency exposures denominated mainly in Euros, and Australian and Singapore dollars.  Under this program, increases or decreases in our foreign currency denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments.   We do not designate these foreign currency contracts as hedges.  We have determined our hedge program to be a non-effective hedge as defined under the FASB-issued authoritative guidance. All movements in the fair value of the foreign currency instruments are recorded within other income, net in our condensed consolidated statements of income.  We do not enter into financial instruments for trading or speculative purposes. We held foreign currency instruments with notional amounts totaling $530.2 million and $462.1 million at September 30, 2018 and June 30, 2018, respectively, to hedge foreign currency fluctuations.  These contracts mature at various dates prior to December 31, 2019.  The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2018 and June 30, 2018 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Balance Sheet Caption </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,299  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">281  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Other assets - current </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,352) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,373) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued expenses </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(534) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(607) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Other long-term liabilities </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(587) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,699) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> </table></div> The following table summarizes the amount and location of gains (losses) associated with our derivative financial instruments for the three months ended September 30, 2018 and September 30, 2017, respectively (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gain /(Loss) Recognized </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Income Statement Caption </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,699) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,646  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Other, net </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other foreign-currency-denominated transactions </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">887  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,282) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other, net </td> </tr> <tr> <td valign="middle" style="width:49.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(812) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(636) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:22.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> </table></div> We are exposed to credit-related losses in the event of non-performance by counter parties to financial instruments. We minimize counterparty credit risk by entering into derivative transactions with major financial institutions and we do not expect material losses as a result of default by our counterparties. </div> </div>

2019-12-31

1646000

-1699000

P3Y

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> U.S., Canada and Latin America </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">172.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">157.9  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">154.0  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">138.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">326.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">296.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">373.9  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">334.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">    </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Combined Europe, Asia and other markets </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">151.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">128.3  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">62.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">60.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">214.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">189.0  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Global revenue </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">324.1  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">286.2  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">216.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">199.4  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">540.8  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">485.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">588.3  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">523.7  </td> </tr> </table></div> </div> </div>

0.61

0.74

0.60

0.73

<div> <div style="margin-left:0pt;margin-right:0pt;"> (11)      Earnings Per Share Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units. For the three months ended September 30, 2018 and September 30, 2017, stock options and restricted stock units covering an aggregate of 10,006 and 6,982 shares of common stock, respectively, were not included in the computation of diluted earnings per share as the effect would have been anti-dilutive. Basic and diluted earnings per share for the three months ended September 30, 2018 and September 30, 2017 are calculated as follows (in thousands except per share data): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Numerator: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net income </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">105,737  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">86,125  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Denominator: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Basic weighted-average common shares outstanding </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">142,668  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">142,247  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Effect of dilutive securities: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Stock options and restricted stock units </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,362  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,233  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Diluted weighted average shares </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">144,030  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">143,480  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Basic earnings per share </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">0.74  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">0.61  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Diluted earnings per share </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">0.73  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">0.60  </td> </tr> </table></div>   </div> </div>

16691000

-3267000

38324000

40587000

41226000

41982000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (6)      Equity Investments The aggregate carrying amount of our equity investments at September 30, 2018 and June 30, 2018, was $42.0 million and $41.2 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets.  The carrying amounts of our equity investments without readily determinable fair values are initially measured at cost and are assessed for impairment and observable price changes in orderly transactions for identifiable or similar investments of the same issuer. We estimate the fair value of our equity investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows. During the three months ended September 30, 2018 and 2017, we recognized $1.7 million and $1.0 million, respectively, of impairment losses related to our equity investments. We have determined, after the impairment charge, that the fair value of our remaining investments exceed their carrying values. The following table shows a reconciliation of the changes in our equity investments during the three months ended September 30, 2018 and September 30, 2017 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">41,226  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38,324  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Investments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">2,467  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,225  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Impairment of equity investments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,711) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(962) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">41,982  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">40,587  </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> (12)      Fair Value Measurements In determining the fair value measurements of our financial assets and liabilities, we consider the principal and most advantageous market in which we transact and consider assumptions that market participants would use when pricing the financial asset or liability. We maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The hierarchies of inputs are as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:27.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:13.55pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:469.85pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:27.00pt;padding:0pt;"> </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:13.55pt;padding:0pt;">  </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:45.00pt;padding:0pt;"> Level 1: </td> <td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:469.85pt;padding:0pt;"> Input prices quoted in an active market for identical financial assets or liabilities; </td> </tr> <tr> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:27.00pt;padding:0pt;"> </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:13.55pt;padding:0pt;">  </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:45.00pt;padding:0pt;"> Level 2: </td> <td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:469.85pt;padding:0pt;"> Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and </td> </tr> <tr> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:27.00pt;padding:0pt;"> </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:13.55pt;padding:0pt;">  </td> <td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:45.00pt;padding:0pt;"> Level 3 </td> <td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:469.85pt;padding:0pt;"> Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market. </td> </tr> </table></div> The following table summarizes our financial assets and liabilities at September 30, 2018 and June 30, 2018, using the valuation input hierarchy (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 1 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 2 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 3 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balances at September 30, 2018 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="top" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(587) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(587) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,082) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,082) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balances at June 30, 2018 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,699) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,699) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,505) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,505) </td> </tr> </table></div> We determine the fair value of our financial assets and liabilities as follows: Foreign currency hedging instruments – These financial instruments are valued using third-party valuation models based on market observable inputs, including interest rate curves, on-market spot currency prices, volatilities and credit risk. Contingent consideration – These liabilities include the fair value estimates of additional future payments that may be required for some of our previous business acquisitions based on the achievement of certain performance milestones. Each potential future payment is valued using the estimated probability of achieving each milestone, which is then discounted to present value. The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2018 and September 30, 2017 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,505) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,580) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Changes in fair value included in operating income </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">183  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Payments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">240  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,082) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,580) </td> </tr> </table></div> We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2018 or June 30, 2018.   </div> </div>

183000

1580000

1505000

1082000

115237000

2283000

48157000

69332000

16868000

122505000

2366000

51077000

69877000

18447000

205149000

3288000

118084000

91708000

48832000

229533000

3255000

127634000

92246000

53797000

215184000

89912000

1005000

69927000

22376000

31964000

242193000

107028000

889000

76557000

22369000

35350000

P15Y

P2Y

2699000

587000

-636000

-812000

1064874000

1072298000

1068944000

1192030000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (4)      Goodwill Changes in the carrying amount of goodwill for three months ended September 30, 2018, and September 30, 2017, were as follows (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,068,944  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,064,874  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Business acquisition </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">125,037  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency translation adjustments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,951) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">7,424  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,192,030  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,072,298  </td> </tr> </table></div>   </div> </div>

7424000

-1951000

125037000

305605000

343093000

29378000

20139000

9239000

32498000

22308000

10190000

962000

1711000

108485000

138881000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (7)      Income Taxes In accordance with ASC 740 Income Taxes, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period. Our income tax returns are based on calculations and assumptions subject to audit by various tax authorities. In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws.  We regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. Any final assessment resulting from tax audits may result in material changes to our past or future taxable income, tax payable or deferred tax assets, and may require us to pay penalties and interest that could materially adversely affect our financial results.  In connection with the audit by the Australian Taxation Office (“ATO”) for the tax years 2009 to 2013, we received Notices of Amended Assessments in March 2018. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed or $75.9 million. We do not agree with the ATO’s assessments and continue to believe we are more likely than not to be successful in defending our position. At September 30, 2018, we have recorded a receivable in prepaid taxes and other non-current assets for the amount paid as we ultimately expect this will be refunded by the ATO. The ATO are performing a risk review and auditing tax years 2014 to 2017. On December 22, 2017, the SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) directing taxpayers to consider the impact of the U.S. legislation as “provisional” when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, we recognized additional estimated income tax expense of $138.0 million during the year ended June 30, 2018 based on our best estimate and interpretation of the U.S. legislation. We are still accumulating data to finalize the underlying calculations, or in certain cases, the U.S. Treasury is expected to issue further guidance on the application of certain provisions of the U.S. legislation and recorded a further $0.5 million in income tax expense during three months ended September 30, 2018. In accordance with SAB 118, the estimated income tax expense is considered provisional and will be finalized before December 22, 2018.   </div> </div>

30157000

125005000

151700000

75900000

38400000

2013

2009

2017

2014

22360000

33144000

-15590000

-99025000

-23317000

-20342000

26942000

15661000

15408000

7703000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (5)      Other Intangible Assets  Other intangible assets were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Developed/core product technology </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">229,533  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">205,149  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(122,505) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(115,237) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Developed/core product technology, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">107,028  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">89,912  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trade names </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">53,797  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">48,832  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(18,447) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(16,868) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trade names, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">35,350  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">31,964  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Non-compete agreements </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,255  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,288  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,366) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,283) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Non-compete agreements, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">889  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,005  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Customer relationships </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">127,634  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">118,084  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(51,077) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(48,157) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Customer relationships, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">76,557  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">69,927  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">92,246  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">91,708  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(69,877) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(69,332) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,369  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,376  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total other intangibles, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">242,193  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">215,184  </td> </tr> </table></div> Intangible assets consist of developed/core product technology, trade names, non-compete agreements, customer relationships, and patents, which we amortize over the estimated useful life of the assets, generally between two and fifteen years. There are no expected residual values related to these intangible assets. In-process research and development is amortized over the estimated useful life of the assets, once the research and development efforts are completed.   </div> </div>

7785000

3708000

7785000

3708000

190833000

206056000

268701000

282555000

75415000

74219000

2453000

2280000

4870000

922000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (13)      Legal Actions and Contingencies Litigation   In the normal course of business, we are subject to routine litigation incidental to our business.  While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole. Taxation Matters As described in note 7 – Income Taxes, we received Notices of Amended Assessments from the ATO for the tax years 2009 to 2013. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed, or $75.9 million. We do not agree with the ATO’s assessments and we continue to believe we are more likely than not to be successful in defending our position. However, if we are not successful, we will not receive a refund of the $75.9 million paid in April 2018 and we would be required to pay the remaining $75.9 million in additional income tax, $38.4 million in accrued interest and $75.9 million in penalties, which would be recorded as income tax expense. The ATO are performing a risk review and auditing tax years 2014 to 2017. In connection with the recent U.S. Tax Act and the analysis of historical tax filings, we identified an administrative oversight in our prior year tax filing relating to a gain on an internal legal entity reorganization.  We have applied for relief from the U.S. Internal Revenue Service (“IRS”) to amend the related tax returns required to correct the administrative oversight, which would indefinitely defer the recognition of this gain. We believe it is more likely than not that we will be granted this relief and therefore, have not recorded a reserve in relation to this matter during the three months ended September 30, 2018. As of September 30, 2018, we were awaiting additional communication from the IRS regarding the amended tax returns. Contingent Obligations Under Recourse Provisions We use independent financing institutions to offer some of our customers financing for the purchase of some of our products. Under these arrangements, if the customer qualifies under the financing institutions’ credit criteria and finances the transaction, the customers repay the financing institution on a fixed payment plan. For some of these arrangements, the customer’s receivable balance is with recourse, either limited or full, whereby we are responsible for repaying the financing company should the customer default. We record a contingent provision, which is estimated based on historical default rates. This is applied to receivables sold with recourse and is recorded in accrued expenses. The following table summarizes the amount of receivables sold with recourse during the three months ended September 30, 2018 and September 30, 2017(in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total receivables sold: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Full recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">10,082  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">4,200  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Limited recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">18,824  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">17,434  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">28,906  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">21,634  </td> </tr> </table></div> The following table summarizes the maximum exposure on outstanding receivables sold with recourse and provision for doubtful accounts at September 30, 2018 and June 30, 2018  (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Maximum exposure on outstanding receivables: </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Full recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,308  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">20,139  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Limited recourse </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">10,190  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">9,239  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">32,498  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">29,378  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contingent provision for receivables with recourse </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,252) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,277) </td> </tr> </table></div>   </div> </div>

1004943000

1167282000

3063923000

3067538000

511249000

421108000

493694000

746174000

0.00175

0.00100

2018-10-31

2023-04-17

700000000

1000000000

1300000000

800000000

200000000

6000000

269988000

517637000

-106083000

144824000

-15424000

-148189000

93983000

48119000

86125000

105737000

500000

42807000

41905000

-4073000

-5251000

193047000

198961000

112558000

144132000

273710000

117304000

-156406000

117024000

36389000

-12872000

924000

534000

-1158000

-2465000

-6073000

3678000

19399000

49698000

52793000

240000

126439000

2242000

2611000

3225000

2467000

16030000

12994000

0.01

2000000

124634000

95687000

-28947000

111757000

3615000

389000

50000000

303000000

19558000

19956000

19227000

19325000

3677000

3589000

3802000

3948000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (8)      Product Warranties Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, for the three months ended September 30, 2018 and September 30, 2017, are as follows (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">19,227  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">19,558  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Warranty accruals for the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,948  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,802  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Warranty costs incurred for the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(3,589) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(3,677) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Foreign currency translation adjustments </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(261) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">273  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">19,325  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">19,956  </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> (3)      Property, Plant and Equipment Property, plant and equipment were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands):  <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Machinery and equipment </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">242,079  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">239,671  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Computer equipment </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">160,396  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">155,069  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Furniture and fixtures </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">50,647  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">51,045  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Vehicles </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">7,532  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">7,399  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Clinical, demonstration and rental equipment </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">88,826  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">92,229  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Leasehold improvements </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">32,437  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">32,169  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Land </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">53,286  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">54,089  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Buildings </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">226,602  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">229,193  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">861,805  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">860,864  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated depreciation and amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(479,983) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(474,314) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Property, plant and equipment, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">381,822  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">386,550  </td> </tr> </table></div>   </div> </div>

860864000

92229000

229193000

155069000

51045000

54089000

32169000

239671000

7399000

861805000

88826000

226602000

160396000

50647000

53286000

32437000

242079000

7532000

386550000

381822000

110000000

86133000

37415000

38791000

2432328000

2243530000

-188798000

2296473000

189000000

523700000

334700000

485600000

296600000

128300000

286200000

157900000

60700000

199400000

138700000

38100000

214400000

588300000

373900000

540800000

326400000

151700000

324100000

172400000

62700000

216700000

154000000

47500000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Revenue Recognition We adopted Accounting Standard Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” on July 1, 2018. We account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. Our revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and data for patient monitoring. Our software as a service (“SaaS”) business offers software access with ongoing support and maintenance services as well as professional services such as training and consulting. Disaggregation of revenue We have determined that we predominantly operate in a single operating segment, which is the sleep and respiratory disorders sector of the medical device industry.  Due to the acquisition of Brightree LLC (“Brightree”) in April 2016, our operations now include the supply of SaaS to medical equipment and home health providers.  However, these SaaS operations, both in terms of revenue and profit, are not material to our global operations and have not been separately reported.  The following table summarizes our net revenue disaggregated by product and region for the three months ended September 30, 2018 compared to September 30, 2017 (in millions): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> U.S., Canada and Latin America </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">172.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">157.9  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">154.0  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">138.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">326.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">296.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">373.9  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">334.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">    </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Combined Europe, Asia and other markets </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">151.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">128.3  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">62.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">60.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">214.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">189.0  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Global revenue </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">324.1  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">286.2  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">216.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">199.4  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">540.8  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">485.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">588.3  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">523.7  </td> </tr> </table></div> Performance obligations and contract balances Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of risk and/or control of our products are provided at a point in time. For most products, we transfer control and recognize a sale when products are shipped from our manufacturing facility or warehouse to the customer. For contracts with customers that contain destination shipping terms, revenue is not recognized until risk has transferred and the goods are delivered to the agreed upon destination. Depending on the terms of the arrangement, we will defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue relate primarily to the provision of software access with maintenance and support, extended warranties on our devices and provision of data for patient monitoring. Generally, deferred revenue will be recognized over a period of one to five years. The following table summarizes our contract balances at September 30, 2018 and June 30, 2018 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> June 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Balance sheet caption </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Contract assets </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Accounts receivable, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">463,743  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">483,681  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Accounts receivable, net </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Unbilled revenue, current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">12,861  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">13,342  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Prepaid expenses and other current assets </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Unbilled revenue, non-current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,718  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">2,973  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Prepaid taxes and other non-current assets </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">    </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Contract liabilities </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Deferred revenue, current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(64,822) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(60,828) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Deferred revenue (current liabilities) </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Deferred revenue, non-current </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(73,810) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(71,596) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Deferred revenue (non-current liabilities) </td> </tr> </table></div> Transaction price determination Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The amount of consideration received and revenue recognized varies with changes in marketing incentives (e.g., rebates, discounts, free goods) and returns offered to customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed. We offer our customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer’s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. We also offer discounts to customers as part of normal business practice and these are deducted from revenue when the sale occurs. Many of our contracts have a single performance obligation which is the shipment of our therapy-based equipment. However, when the contract has multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to the performance obligation. Accounting and practical expedient elections We have elected to account for shipping and handling activities as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue.  We have adopted two practical expedients including the “right to invoice” practical expedient, which allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date and which is relevant for some of our SaaS contracts. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less. </div> </div>

523659000

588279000

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 1 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 2 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Level 3 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balances at September 30, 2018 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="top" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(587) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(587) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,082) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,082) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balances at June 30, 2018 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,699) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,699) </td> </tr> <tr> <td valign="middle" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,505) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(1,505) </td> </tr> </table></div> </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> June 30, 2018 </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Developed/core product technology </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">229,533  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">205,149  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(122,505) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(115,237) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Developed/core product technology, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">107,028  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">89,912  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trade names </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">53,797  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">48,832  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(18,447) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(16,868) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Trade names, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">35,350  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">31,964  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Non-compete agreements </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,255  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,288  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,366) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,283) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Non-compete agreements, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">889  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,005  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Customer relationships </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">127,634  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">118,084  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(51,077) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(48,157) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Customer relationships, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">76,557  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">69,927  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">92,246  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">91,708  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(69,877) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(69,332) </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,369  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">22,376  </td> </tr> <tr> <td valign="middle" style="width:73.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total other intangibles, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">242,193  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">215,184  </td> </tr> </table></div> </div> </div>

143849000

147303000

11948000

12477000

P4Y

P1Y

2314

63.80

7093

104.57

1644754

1636416

62.89

63.08

P1Y7M6D

P1Y4M24D

2911

64.90

P7Y

51100000

500000

17800000

52.43

183

1205826

1193670

60.48

60.65

P4Y4M24D

P4Y1M6D

42.84

52.02

671647

11466000

11975000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (1)      Summary of Significant <a name="NOTESTOCONDENSEDCONSOLIDATEDFINANCIALSTA"></a>Accounting Policies Organization and Basis of Presentation ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group.  Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea.  Our manufacturing operations are located in Australia, Singapore, Malaysia, France, China and the United States.  Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, China, Norway and Sweden. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and the rules of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods.  The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2019. The condensed consolidated financial statements for the three months ended September 30, 2018 and September 30, 2017 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2018. Revenue Recognition We adopted Accounting Standard Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” on July 1, 2018. We account for a contract with a customer when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. Our revenue relates primarily to the sale of our products that are therapy-based equipment. Some contracts include additional performance obligations such as the provision of extended warranties and data for patient monitoring. Our software as a service (“SaaS”) business offers software access with ongoing support and maintenance services as well as professional services such as training and consulting. Disaggregation of revenue We have determined that we predominantly operate in a single operating segment, which is the sleep and respiratory disorders sector of the medical device industry.  Due to the acquisition of Brightree LLC (“Brightree”) in April 2016, our operations now include the supply of SaaS to medical equipment and home health providers.  However, these SaaS operations, both in terms of revenue and profit, are not material to our global operations and have not been separately reported.  The following table summarizes our net revenue disaggregated by product and region for the three months ended September 30, 2018 compared to September 30, 2017 (in millions): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> 2017 </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> U.S., Canada and Latin America </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">172.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">157.9  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">154.0  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">138.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">326.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">296.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">373.9  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">334.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">    </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Combined Europe, Asia and other markets </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">151.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">128.3  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">62.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">60.7  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">214.4  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">189.0  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Global revenue </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Devices </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">324.1  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">286.2  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">216.7  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">199.4  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total devices and masks </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">540.8  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">485.6  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Software as a Service </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">47.5  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">38.1  </td> </tr> <tr> <td valign="middle" style="width:73.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">588.3  </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;height:1.00pt;color:#000000;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">523.7  </td> </tr> </table></div> Performance obligations and contract balances Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied; generally this occurs with the transfer of risk and/or control of our products are provided at a point in time. For most products, we transfer control and recognize a sale when products are shipped from our manufacturing facility or warehouse to the customer. For contracts with customers that contain destination shipping terms, revenue is not recognized until risk has transferred and the goods are delivered to the agreed upon destination. Depending on the terms of the arrangement, we will defer the recognition of a portion of the consideration received when performance obligations are not yet satisfied. Consideration received from customers in advance of revenue recognition is classified as deferred revenue. Performance obligations resulting in deferred revenue relate primarily to the provision of software access with maintenance and support, extended warranties on our devices and provision of data for patient monitoring. Generally, deferred revenue will be recognized over a period of one to five years. The following table summarizes our contract balances at September 30, 2018 and June 30, 2018 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> September 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> June 30, 2018 </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Balance sheet caption </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Contract assets </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Accounts receivable, net </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">463,743  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">483,681  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Accounts receivable, net </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Unbilled revenue, current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">12,861  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">13,342  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Prepaid expenses and other current assets </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Unbilled revenue, non-current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">3,718  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">2,973  </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Prepaid taxes and other non-current assets </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">    </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Contract liabilities </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Deferred revenue, current </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(64,822) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(60,828) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Deferred revenue (current liabilities) </td> </tr> <tr> <td valign="middle" style="width:44.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Deferred revenue, non-current </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(73,810) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(71,596) </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Deferred revenue (non-current liabilities) </td> </tr> </table></div> Transaction price determination Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The amount of consideration received and revenue recognized varies with changes in marketing incentives (e.g., rebates, discounts, free goods) and returns offered to customers and their customers. When we give customers the right to return eligible products and receive credit, returns are estimated based on an analysis of historical experience. However, returns of products, excluding warranty related returns, are infrequent and insignificant. We adjust the estimate of revenue at the earlier of when the most likely amount of consideration can be estimated, the amount expected to be received changes, or when the consideration becomes fixed. We offer our customers cash or product rebates based on volume or sales targets measured over quarterly or annual periods. We estimate rebates based on each customer’s expected achievement of its targets. In accounting for these rebate programs, we reduce revenue ratably as sales occur over the rebate period by the expected value of the rebates to be returned to the customer. Rebates measured over a quarterly period are updated based on actual sales results and, therefore, no estimation is required to determine the reduction to revenue. For rebates measured over annual periods, we update our estimates on a quarterly basis based on actual sales results and updated forecasts for the remaining rebate periods. We also offer discounts to customers as part of normal business practice and these are deducted from revenue when the sale occurs. Many of our contracts have a single performance obligation which is the shipment of our therapy-based equipment. However, when the contract has multiple performance obligations, we generally use an observable price to determine the stand-alone selling price by reference to pricing and discounting practices for the specific product or service when sold separately to similar customers. Revenue is then allocated proportionately, based on the determined stand-alone selling price, to the performance obligation. Accounting and practical expedient elections We have elected to account for shipping and handling activities as a fulfillment cost within cost of sales, and record shipping and handling costs collected from customers in net revenue. We have also elected for all taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, to be excluded from revenue.  We have adopted two practical expedients including the “right to invoice” practical expedient, which allows us to recognize revenue in the amount of the invoice when it corresponds directly with the value of performance completed to date and which is relevant for some of our SaaS contracts. The second practical expedient adopted permits relief from considering a significant financing component when the payment for the good or service is expected to be one year or less. Provision for Warranty We provide for the estimated cost of product warranties at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision. New Accounting Pronouncements (a)  Recently issued accounting standards not yet adopted ASU No. 2016-02, “Leases” In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (Topic 842). Under the new guidance, lessees are required to recognize a right-of-use asset and a lease liability on the balance sheet for all leases, other than those that meet the definition of a short-term lease. This update will establish a lease asset and lease liability by lessees for those leases classified as operating under current GAAP. Leases will be classified as either operating or finance under the new guidance. Operating leases will result in straight-line expense in the income statement, similar to current operating leases, and finance leases will result in more expense being recognized in the earlier years of the lease term, similar to current capital leases.  For lessors, the update will more closely align lease accounting to comparable guidance in the new revenue standards described. The new standard is effective for us beginning in the first quarter of the year ending June 30, 2020 and early application is permitted. ASU 2016-02 will be adopted on a modified retrospective transition basis. There is a practical expedient available that would permit any leases that existed at the date of adoption to continue to be accounted for in accordance with the previous GAAP, ASC 840. We are still evaluating whether we will adopt this practical expedient. We formed an implementation team during the year ended June 30, 2018 to oversee adoption of the new standard. The implementation team has established a project plan as well as initiated collecting global data on our lease agreements. There are a number of steps in the team’s project plan that remain to be completed including: executing global education program, designing the system solution for data collation and balance calculations, evaluating the impact, and working through required changes to systems, business processes and controls to support the adoption of the new leases standard. While the formal impact assessment is ongoing, we expect this amendment will affect the way we account for operating leases where we are the lessee (as described above), require reassessment of how we account for revenue where we are the lessor and will result in increased disclosures for all lease arrangements. We are still evaluating the impact the standard will have on our financial statements. (b)  Recently adopted accounting pronouncements ASU No. 2014-09, “Revenue from Contracts with Customers” In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. Since its initial release, the FASB has issued several amendments to the standard, which include clarification of accounting guidance related to identification of performance obligations, intellectual property licenses, and principal vs. agent considerations. ASU 2014-09 and all subsequent amendments (collectively, the “new revenue recognition standards”) replaced most existing revenue recognition guidance in U.S. GAAP during the current quarter when it became effective. The guidance also requires improved disclosures on the nature, amount, timing, and uncertainty of revenue that is recognized. Effective July 1, 2018, we adopted the new revenue recognition standards and applied its provisions to all contracts using the modified retrospective method. Application of the new provisions did not have a material impact on our financial statements and no cumulative-effect adjustment was calculated or recognized. The comparative information has not been restated; however, if it were there would be no change in the accounting treatment. Refer to the “Revenue Recognition” section above for further details about our revenue recognition following adoption of the new revenue recognition standards. ASU No. 2016-01, "Financial Instruments - Overall" In January 2016, the FASB issued ASU No. 2016-01, "Financial Instruments - Overall" (Topic 825-10). The amendments address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments, and require equity investments, other than equity-method investments, to be measured at fair value with changes in fair value recognized through net income. The amendments also simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment for impairment quarterly at each reporting period. We adopted ASU 2016-01 during the quarter ended September 30, 2018 and elected to apply the practical expedient for measuring equity investments that do not have readily determinable fair market.  Based on our elections, our strategic equity investments that do not have readily determinable fair values are measured at cost, less any impairments, plus or minus changes resulting from observable price changes in orderly transactions for identifiable or similar investments of the same issuer. The measurement alternative was applied prospectively and the adoption of ASU 2016-01 did not result in an adjustment to retained earnings. ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory” In October 2016, the FASB issued Accounting Standard Update ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory” (Topic 740). Under the new guidance, an entity is required to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs and eliminates the exception for an intra-entity transfer of an asset other than inventory. ASU 2016-16 became effective during the three months ended September 30, 2018 and is required to be adopted on a modified retrospective basis, with a cumulative-effect adjustment recorded directly to retained earnings for intra-entity transfers that occur before the adoption date. Accordingly, we recognized the following reclassifications upon adoption (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Balance Sheet Caption </td> <td valign="top" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> As reported balance June 30, 2018 </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Adoption of ASU 2016-16 Increase/(Decrease) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> Revised balance July 1, 2018 </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Assets </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Prepaid expenses and other current assets </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">124,634  </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(28,947) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> $ </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">95,687  </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Prepaid taxes and other non-current assets </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">273,710  </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(156,406) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">117,304  </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Deferred income taxes </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">53,818  </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(3,445) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">50,373  </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;"> Equity </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:59.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;"> Retained Earnings </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">2,432,328  </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(188,798) </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">2,243,530  </td> </tr> </table></div>   </div> </div>

-273000

261000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Provision for Warranty We provide for the estimated cost of product warranties at the time the related revenue is recognized. We determine the amount of this provision by using a financial model, which takes into consideration actual historical expenses and potential risks associated with our different products. We use this financial model to calculate the future probable expenses related to warranty and the required level of the warranty provision. Although we engage in product improvement programs and processes, our warranty obligation is affected by product failure rates and costs incurred to correct those product failures. Should actual product failure rates or estimated costs to repair those product failures differ from our estimates, we would be required to revise our estimated warranty provision. </div> </div>

2058980000

1900256000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (10)      Stockholders’ Equity Common Stock.    During the three months ended September 30, 2018, we repurchased 200,000 shares at an aggregate purchase price of $22.8 million under our share repurchase program.  Since the inception of our share repurchase programs and through September 30, 2018, we have repurchased a total of 41.8 million shares for an aggregate of $1.6 billion.  Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. At September 30, 2018,  12.9 million additional shares can be repurchased under the approved share repurchase program. Preferred Stock.    In April 1997, the board of directors designated 2.0 million shares of our $0.01 par value preferred stock as Series A Junior Participating Preferred Stock. No shares were issued or outstanding at September 30, 2018 and June 30, 2018. Stock Options and Restricted Stock Units.    We have granted stock options and restricted stock units to personnel, including officers and directors, in accordance with the amended and restated ResMed Inc. 2009 Incentive Award Plan (as amended and restated, the “2009 Plan”).  The options have expiration dates of seven years from the date of grant and the options and restricted stock units vest over one to four years.  At September 30, 2018, the maximum number of shares of our common stock authorized for issuance under the 2009 Plan was 51.1 million shares. The number of securities remaining available for future issuance under the 2009 Plan at September 30, 2018 was 17.8 million.   The following table summarizes option activity during the three months ended September 30, 2018: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted Average Exercise Price </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted Average Remaining Contractual Term in Years </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding at beginning of period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,205,826  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">60.48  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.4 </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Granted </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exercised </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(11,973) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">42.84  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Forfeited </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(183) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">52.02  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding at end of period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,193,670  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">60.65  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.1 </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Exercise price of granted options </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  - </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:11.20%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Options exercisable at end of period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">671,647  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">52.43  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="top" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> </table></div> The following table summarizes the activity of restricted stock units during the three months ended September 30, 2018: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> </td> <td valign="top" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Restricted Stock Units </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted Average Grant-Date Fair Value </td> <td valign="bottom" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted Average Remaining Contractual Term in Years </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding at beginning of period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,644,754  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">62.89  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1.6 </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Granted </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">7,093  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">104.57  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="top" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Vested </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,911) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">64.90  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="top" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expired / cancelled </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(10,206) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">63.80  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Forfeited </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">(2,314) </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">63.80  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="top" style="width:11.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:60.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Outstanding at end of period </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">1,636,416  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:01.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="middle" style="width:10.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap">63.08  </td> <td valign="middle" style="width:01.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="middle" style="width:11.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1.4 </td> </tr> </table></div> Employee Stock Purchase Plan (the “ESPP”).    Under the ESPP, we offer participants the right to purchase shares of our common stock at a discount during successive offering periods. At September 30, 2018, the number of shares remaining available for future issuance under the ESPP is 0.5 million shares.   </div> </div>

11973

12900000

41636234

41836234

200000

1600412000

1623256000

22800000

1233000

1362000

143480000

144030000

142247000

142668000

EX-101.SCH 6 rmd-20180930.xsd EX-101.SCH 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements Of Income link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements Of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Inventories (Schedule Of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Property, Plant And Equipment (Components Of Property, Plant And Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Other Intangible Assets (Schedule Of Other Intangible Assets, Net) (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Debt (Schedule Of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 41403 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Property, Plant And Equipment link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Equity Investments link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Product Warranties link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Legal Actions And Contingencies link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Derivative Instruments And Hedging Activities link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30103 - Disclosure - Summary Of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Property, Plant And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Equity Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Product Warranties (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Legal Actions And Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - Derivative Instruments And Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details) link:presentationLink link:calculationLink link:definitionLink 40104 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16) (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Other Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Equity Investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Equity Investments (Schedule Of Reconciliation Of Changes In Equity Investments) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stockholders' Equity (Schedule Of Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Earnings Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Legal Actions And Contingencies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - Legal Actions And Contingencies (Summary Of Receivables Sold With Recourse) (Details) link:presentationLink link:calculationLink link:definitionLink 41303 - Disclosure - Legal Actions And Contingencies (Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision) (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Derivative Instruments And Hedging Activities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Business Combinations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 rmd-20180930_cal.xml EX-101.CAL EX-101.DEF 8 rmd-20180930_def.xml EX-101.DEF EX-101.LAB 9 rmd-20180930_lab.xml EX-101.LAB Document And Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Entity Registrant Name Entity Filer Category Entity Central Index Key Entity Small Business Entity Emerging Growth Company Amendment Flag Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Trading Symbol Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Condensed Consolidated Balance Sheets [Abstract] Assets [Abstract] Assets Current assets: Cash and cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net Accounts receivable, net of allowance for doubtful accounts of $21,928 and $19,258 at September 30, 2018 and June 30, 2018, respectively Inventories, net (note 5) Total inventories Inventories (note 2) Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Non-current assets: Property, plant and equipment, net (note 6) Property, plant and equipment, net Property, plant and equipment, net (note 3) Goodwill Balance at the end of the period Balance at the beginning of the period Goodwill (note 4) Finite-Lived Intangible Assets, Net Other intangible assets, net (note 5) Total other intangibles, net Deferred income taxes Other Assets, Noncurrent Prepaid taxes and other non-current assets Assets, Noncurrent Total non-current assets Assets, Total Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders’ Equity Equity Current liabilities: Accounts payable Accrued Liabilities Current Accrued expenses Contract with Customer, Liability, Current Deferred revenue, current Deferred revenue Accrued Income Taxes, Current Income taxes payable Income taxes payable (note 7) Short-term debt Short-term debt, net (note 9) Short-term debt, net Liabilities, Current Total current liabilities Non-current liabilities: Contract with Customer, Liability, Noncurrent Deferred revenue, non-current Deferred revenue Non-current deferred tax liability Deferred income taxes Other Liabilities, Noncurrent Other long-term liabilities Long-term Debt Total Long-term debt, net Long-term debt, net (note 9) Income taxes payable, noncurrent Long-term income taxes payable (note 7) Liabilities, Noncurrent Total non-current liabilities Liabilities, Total Total liabilities Commitments and Contingencies Commitments and contingencies (note 13) Stockholders' equity Abstract Stockholders’ equity: (note 10) Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued Common stock, $0.004 par value, 350,000,000 shares authorized; 181,080,475 issued and 139,994,241 outstanding at December 31, 2015 and 179,660,939 issued and 140,474,705 outstanding at June 30, 2015 Common stock, $0.004 par value, 350,000,000 shares authorized; 184,330,350 issued and 142,494,116 outstanding at September 30, 2018 and 184,315,866 issued and 142,679,632 outstanding at June 30, 2018 Additional Paid In Capital Common Stock Additional paid-in capital Retained earnings Treasury stock, at cost, 41,086,234 shares at December 31, 2015, and 39,186,234 shares at June 30, 2015 Treasury stock, at cost, 41,836,234 shares at September 30, 2018 and 41,636,234 shares at June 30, 2018 Total cost of shares repurchased pursuant to the repurchase program Accumulated other comprehensive income Accumulated other comprehensive loss Stockholders' Equity Total stockholders' equity Liabilities and Stockholders' Equity Total liabilities and stockholders' equity Accounts receivable, net allowance for doubtful accounts Preferred stock, par value Preferred stock at par value Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares held Total number of shares repurchased pursuant to the repurchase program Condensed Consolidated Statements Of Income [Abstract] Revenues Net revenue Cost of sales Cost of sales (excluding amortization of acquired intangible assets) Gross Profit Gross profit Operating expenses: Selling, general and administrative Research and development The aggregate expense charged against earnings to allocate the cost of acquired intangible assets. Amortization of acquired intangible assets 1 Amortization of acquired intangible assets Operating Expenses Total operating expenses Operating Income (Loss) Income from operations Other income (loss), net: Interest income Interest Expense Interest expense Other Nonoperating Income (Expense) Other, net Nonoperating Income (Expense) Total other income (loss), net Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Cumulative Effects of Changes in Accounting Principles, Noncontrolling Interest Income before income taxes Income Tax Expense Benefit Income taxes Net income Net income Net income Basic earnings per share Basic earnings per share (note 11) Basic earnings per share Diluted earnings per share (note 2-k) Diluted earnings per share Diluted earnings per share (note 11) Common Stock, Dividends, Per Share, Declared Dividend declared per share Weighted average shares used to calculate basic earnings per share Basic shares outstanding (000's) Basic weighted-average common shares outstanding Diluted shares outstanding (000's) Diluted shares outstanding (000's) Diluted weighted average shares Condensed Consolidated Statements Of Comprehensive Income [Abstract] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation (loss) gain adjustments Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) Condensed Consolidated Statements Of Cash Flows [Abstract] Cash flows from operating activities: Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization Stock-based compensation costs Write-down of cost-method investments Impairment of equity investments Impairment of equity investments Impairment losses related to cost-method investments Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Changes in fair value of business combination contingent consideration (note 12) Changes in operating assets and liabilities, net of effect of acquisitions: Increase (Decrease) in Accounts Receivables Accounts receivable Inventories, net Inventories Prepaid expenses, net deferred income taxes and other current assets Prepaid expenses, net deferred income taxes and other current assets Accounts payable, accrued expenses and other Net cash provided by operating activities Net cash provided by operating activities Cash flows from investing activities: Purchases of property plant and equipment Purchases of property, plant and equipment Patent registration costs Patent registration costs Business acquisitions, net of cash acquired Business acquisitions, net of cash acquired Purchase of cost-method investments Investment in equity investments Investments Proceeds from exercise of foreign currency options Proceeds (payments) on maturity of foreign currency contracts Net cash used in investing activities Net cash used in investing activities Cash flows from financing activities: Proceeds from issuance of common stock, net Purchases of treasury stock Purchases of treasury stock Payment of business combination earn-out Payments of business combination contingent consideration (note 12) Proceeds from Issuance of Long-term Debt Proceeds from borrowings, net of borrowing costs Repayment of borrowings Repayment of borrowings Payments of Dividends Dividend paid Net cash -used in/provided by financing activities Net cash provided by (used in) financing activities Effect of exchange rate changes on cash Net increase in cash and cash equivalents Net increaase (decrease) in cash and cash equivalents Supplemental disclosure of cash flow information: Income Taxes Paid, Net Income taxes paid, net of refunds Interest Paid, Net Interest paid Noncash or Part Noncash Acquisition, Value of Assets Acquired Fair value of assets acquired, excluding cash Business Acquisition, Purchase Price Allocation, Liabilities Assumed Liabilities assumed Goodwill, Other Increase (Decrease) Business acquisition Goodwill on acquisition Noncash or Part Noncash Acquisition, Payables Assumed Deferred payments Payments To Acquire Businesses Gross Cash paid for acquisition Summary Of Significant Accounting Policies [Abstract] Summary of Significant Accounting Policies [Text Block] Summary Of Significant Accounting Policies Inventories [Abstract] Inventories [Text Block] Inventories Property, Plant And Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property, Plant And Equipment Goodwill and Intangible Assets Disclosure [Abstract] Goodwill Disclosure [Text Block] Goodwill Intangible Assets Disclosure [Text Block] Other Intangible Assets Equity Investments [Abstract] Equity Method Investments and Joint Ventures Disclosure [Text Block] Equity Investments Income Taxes [Abstract] Income Tax Disclosure [Text Block] Income Taxes Product Warranties [Abstract] Product Warranty Disclosure [Text Block] Product Warranties Debt [Abstract] Debt Disclosure [Text Block] Debt Stockholders' Equity [Abstract] Stockholders Equity Note Disclosure Text Block Stockholders' Equity Earnings Per Share [Abstract] Earnings Per Share [Text Block] Earnings Per Share Fair Value Measurements [Abstract] Fair Value Measurements [Text Block] Fair Value Measurements Legal Actions And Contingencies [Abstract] Legal Actions and Contingencies [Text block] Legal Actions And Contingencies Derivative Instruments And Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Text Block] Derivative Instruments And Hedging Activities Business Combinations [Abstract] Business Combination Disclosure [Text Block] Business Combinations Organization And Basis Of Presentation [Policy Text Bock] Organization And Basis Of Presentation [Policy Text Bock] Organization And Basis Of Presentation Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Standard Product Warranty, Policy [Policy Text Block] Provision For Warranty New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements Disaggregation of Revenue [Table Text Block] Summary Of Net Revenue Disaggregated By Product And Region Contract with Customer, Asset and Liability [Table Text Block] Summary Of Contract Balances Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16 Schedule of Inventory, Current [Table Text Block] Schedule Of Inventories Property, Plant and Equipment [text bock] Components Of Property, Plant And Equipment Schedule of Goodwill [Table Text Block] Schedule Of Changes In Carrying Amount Of Goodwill Other Intangible Assets [Text Block] Schedule Of Other Intangible Assets Equity Method Investments [Table Text Block] Schedule Of Reconciliation Of Changes In Equity Investments Schedule of Product Warranty Liability [Table Text Block] Schedule Of Changes In Liability For Warranty Costs Schedule of Debt [Table Text Block] Schedule Of Debt Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule Of Option Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule Of Activity Of Restricted Stock Units Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block] Schedule Of Basic And Diluted Earnings Per Share Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary Of Financial Assets And Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs Schedule Of Contingent Obligation Receivables Sold With Recourse [Table Text Block] Schedule Of Contingent Obligation Receivables Sold With Recourse [Table Text Block] Summary Of Receivables Sold With Recourse Schedule Of Contingent Obligations Under Recourse Provisions [Table Text Block] Schedule Of Contingent Obligations Under Recourse Provisions [Table Text Block] Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Summary Of Amount And Location Of Derivative Financial Instruments Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] Summary Of Gains (Losses) Associated With Derivative Financial Instruments Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Range [Axis] Range [Member] Range [Domain] Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Term Of Contract Under Revenue Recognition Term Of Contract Under Revenue Recognition Deferred revenue recognized over a period of Disaggregation of Revenue [Table] EX-101.PRE 10 rmd-20180930_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2018	Oct. 22, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	RESMED INC
Entity Filer Category	Large Accelerated Filer
Entity Central Index Key	0000943819
Entity Small Business	false
Entity Emerging Growth Company	false
Amendment Flag	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	rmd
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		142,499,749

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Current assets:
Cash and cash equivalents	$ 230,188	$ 188,701
Accounts receivable, net of allowance for doubtful accounts of $21,928 and $19,258 at September 30, 2018 and June 30, 2018, respectively	463,743	483,681
Inventories (note 2)	282,555	268,701
Prepaid expenses and other current assets	111,757	124,634
Total current assets	1,088,243	1,065,717
Non-current assets:
Property, plant and equipment, net (note 3)	381,822	386,550
Goodwill (note 4)	1,192,030	1,068,944
Other intangible assets, net (note 5)	242,193	215,184
Deferred income taxes	46,226	53,818
Prepaid taxes and other non-current assets	117,024	273,710
Total non-current assets	1,979,295	1,998,206
Total assets	3,067,538	3,063,923
Current liabilities:
Accounts payable	98,709	92,723
Accrued expenses	169,465	185,805
Deferred revenue	64,822	60,828
Income taxes payable (note 7)	76,137	160,427
Short-term debt, net (note 9)	11,975	11,466
Total current liabilities	421,108	511,249
Non-current liabilities:
Deferred revenue	73,810	71,596
Deferred income taxes	16,091	13,084
Other long-term liabilities	534	924
Long-term debt, net (note 9)	517,637	269,988
Long-term income taxes payable (note 7)	138,102	138,102
Total non-current liabilities	746,174	493,694
Total liabilities	1,167,282	1,004,943
Commitments and contingencies (note 13)
Stockholders’ equity: (note 10)
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued
Common stock, $0.004 par value, 350,000,000 shares authorized; 184,330,350 issued and 142,494,116 outstanding at September 30, 2018 and 184,315,866 issued and 142,679,632 outstanding at June 30, 2018	570	571
Additional paid-in capital	1,463,669	1,450,821
Retained earnings	2,296,473	2,432,328
Treasury stock, at cost, 41,836,234 shares at September 30, 2018 and 41,636,234 shares at June 30, 2018	(1,623,256)	(1,600,412)
Accumulated other comprehensive loss	(237,200)	(224,328)
Total stockholders' equity	1,900,256	2,058,980
Total liabilities and stockholders' equity	$ 3,067,538	$ 3,063,923

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, net allowance for doubtful accounts	$ 21,928	$ 19,258
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.004	$ 0.004
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares issued	184,330,350	184,315,866
Common stock, shares outstanding	142,494,116	142,679,632
Treasury stock, shares held	41,836,234	41,636,234

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Condensed Consolidated Statements Of Income [Abstract]
Net revenue	$ 588,279	$ 523,659
Cost of sales (excluding amortization of acquired intangible assets)	245,186	218,054
Gross profit	343,093	305,605
Operating expenses:
Selling, general and administrative	147,303	143,849
Research and development	38,791	37,415
Amortization of acquired intangible assets	12,867	11,783
Total operating expenses	198,961	193,047
Income from operations	144,132	112,558
Other income (loss), net:
Interest income	922	4,870
Interest expense	(3,708)	(7,785)
Other, net	(2,465)	(1,158)
Total other income (loss), net	(5,251)	(4,073)
Income before income taxes	138,881	108,485
Income taxes	33,144	22,360
Net income	$ 105,737	$ 86,125
Basic earnings per share (note 11)	$ 0.74	$ 0.61
Diluted earnings per share (note 11)	0.73	0.60
Dividend declared per share	$ 0.37	$ 0.35
Basic shares outstanding (000's)	142,668	142,247
Diluted shares outstanding (000's)	144,030	143,480

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Condensed Consolidated Statements Of Comprehensive Income [Abstract]
Net income	$ 105,737	$ 86,125
Other comprehensive income (loss):
Foreign currency translation (loss) gain adjustments	(12,872)	36,389
Comprehensive income (loss)	$ 92,865	$ 122,514

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income	$ 105,737	$ 86,125
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,424	29,571
Stock-based compensation costs	12,477	11,948
Impairment of equity investments	1,711	962
Changes in fair value of business combination contingent consideration (note 12)	(183)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	20,342	23,317
Inventories	(15,661)	(26,942)
Prepaid expenses, net deferred income taxes and other current assets	(7,703)	(15,408)
Accounts payable, accrued expenses and other	(99,025)	(15,590)
Net cash provided by operating activities	48,119	93,983
Cash flows from investing activities:
Purchases of property, plant and equipment	(12,994)	(16,030)
Patent registration costs	(2,611)	(2,242)
Business acquisitions, net of cash acquired	(126,439)
Investment in equity investments	(2,467)	(3,225)
Proceeds (payments) on maturity of foreign currency contracts	(3,678)	6,073
Net cash used in investing activities	(148,189)	(15,424)
Cash flows from financing activities:
Proceeds from issuance of common stock, net	389	3,615
Purchases of treasury stock	(19,399)
Payments of business combination contingent consideration (note 12)	(240)
Proceeds from borrowings, net of borrowing costs	303,000	50,000
Repayment of borrowings	(86,133)	(110,000)
Dividend paid	(52,793)	(49,698)
Net cash provided by (used in) financing activities	144,824	(106,083)
Effect of exchange rate changes on cash	(3,267)	16,691
Net increaase (decrease) in cash and cash equivalents	41,487	(10,833)
Cash and cash equivalents at beginning of period	188,701	821,935
Cash and cash equivalents at end of period	230,188	811,102
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	125,005	30,157
Interest paid	3,708	7,785
Fair value of assets acquired, excluding cash	42,807
Liabilities assumed	(41,905)
Goodwill on acquisition	125,037
Deferred payments	500
Cash paid for acquisition	$ 126,439

XML 17 R7.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies

3 Months Ended

Sep. 30, 2018

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

(1) Summary of Significant Accounting Policies

Organization and Basis of Presentation

Revenue Recognition

Disaggregation of revenue



	Three Months Ended September 30,
	2018		2017
U.S., Canada and Latin America
Devices	$	172.4	$	157.9
Masks		154.0		138.7
Total devices and masks	$	326.4	$	296.6
Software as a Service		47.5		38.1
Total	$	373.9	$	334.7

Combined Europe, Asia and other markets
Devices	$	151.7	$	128.3
Masks		62.7		60.7
Total	$	214.4	$	189.0

Global revenue
Devices	$	324.1	$	286.2
Masks		216.7		199.4
Total devices and masks	$	540.8	$	485.6
Software as a Service		47.5		38.1
Total	$	588.3	$	523.7

Performance obligations and contract balances



	September 30, 2018		June 30, 2018		Balance sheet caption
Contract assets
Accounts receivable, net	$	463,743	$	483,681	Accounts receivable, net
Unbilled revenue, current		12,861		13,342	Prepaid expenses and other current assets
Unbilled revenue, non-current		3,718		2,973	Prepaid taxes and other non-current assets

Contract liabilities
Deferred revenue, current		(64,822)		(60,828)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(73,810)		(71,596)	Deferred revenue (non-current liabilities)

Transaction price determination

Accounting and practical expedient elections

Provision for Warranty

New Accounting Pronouncements

(a) Recently issued accounting standards not yet adopted

ASU No. 2016-02, “Leases”

(b) Recently adopted accounting pronouncements

ASU No. 2014-09, “Revenue from Contracts with Customers”

ASU No. 2016-01, "Financial Instruments - Overall"

ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory”



Balance Sheet Caption	As reported balance June 30, 2018		Adoption of ASU 2016-16 Increase/(Decrease)		Revised balance July 1, 2018
Assets
Prepaid expenses and other current assets	$	124,634	$	(28,947)	$	95,687
Prepaid taxes and other non-current assets		273,710		(156,406)		117,304
Deferred income taxes		53,818		(3,445)		50,373
Equity
Retained Earnings		2,432,328		(188,798)		2,243,530

XML 18 R8.htm IDEA: XBRL DOCUMENT

Inventories

3 Months Ended

Sep. 30, 2018

Inventories [Abstract]

Inventories

(2) Inventories

Inventories were comprised of the following at September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Raw materials	$	74,219	$	75,415
Work in progress		2,280		2,453
Finished goods		206,056		190,833
Total inventories	$	282,555	$	268,701

XML 19 R9.htm IDEA: XBRL DOCUMENT

Property, Plant And Equipment

3 Months Ended

Sep. 30, 2018

Property, Plant And Equipment [Abstract]

Property, Plant And Equipment

(3) Property, Plant and Equipment

Property, plant and equipment were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Machinery and equipment	$	242,079	$	239,671
Computer equipment		160,396		155,069
Furniture and fixtures		50,647		51,045
Vehicles		7,532		7,399
Clinical, demonstration and rental equipment		88,826		92,229
Leasehold improvements		32,437		32,169
Land		53,286		54,089
Buildings		226,602		229,193
		861,805		860,864
Accumulated depreciation and amortization		(479,983)		(474,314)
Property, plant and equipment, net	$	381,822	$	386,550

XML 20 R10.htm IDEA: XBRL DOCUMENT

Goodwill

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

(4) Goodwill

Changes in the carrying amount of goodwill for three months ended September 30, 2018, and September 30, 2017, were as follows (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	1,068,944	$	1,064,874
Business acquisition		125,037		-
Foreign currency translation adjustments		(1,951)		7,424
Balance at the end of the period	$	1,192,030	$	1,072,298

XML 21 R11.htm IDEA: XBRL DOCUMENT

Other Intangible Assets

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets

(5) Other Intangible Assets

Other intangible assets were comprised of the following as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Developed/core product technology	$	229,533	$	205,149
Accumulated amortization		(122,505)		(115,237)
Developed/core product technology, net		107,028		89,912
Trade names		53,797		48,832
Accumulated amortization		(18,447)		(16,868)
Trade names, net		35,350		31,964
Non-compete agreements		3,255		3,288
Accumulated amortization		(2,366)		(2,283)
Non-compete agreements, net		889		1,005
Customer relationships		127,634		118,084
Accumulated amortization		(51,077)		(48,157)
Customer relationships, net		76,557		69,927
Patents		92,246		91,708
Accumulated amortization		(69,877)		(69,332)
Patents, net		22,369		22,376
Total other intangibles, net	$	242,193	$	215,184

XML 22 R12.htm IDEA: XBRL DOCUMENT

Equity Investments

3 Months Ended

Sep. 30, 2018

Equity Investments [Abstract]

Equity Investments

(6) Equity Investments

The following table shows a reconciliation of the changes in our equity investments during the three months ended September 30, 2018 and September 30, 2017 (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	41,226	$	38,324
Investments		2,467		3,225
Impairment of equity investments		(1,711)		(962)
Balance at the end of the period	$	41,982	$	40,587

XML 23 R13.htm IDEA: XBRL DOCUMENT

Income Taxes	3 Months Ended
Income Taxes	Sep. 30, 2018
Income Taxes [Abstract]
Income Taxes	(7) Income Taxes In accordance with ASC 740 Income Taxes, each interim reporting period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period. Our income tax returns are based on calculations and assumptions subject to audit by various tax authorities. In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws. We regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. Any final assessment resulting from tax audits may result in material changes to our past or future taxable income, tax payable or deferred tax assets, and may require us to pay penalties and interest that could materially adversely affect our financial results. In connection with the audit by the Australian Taxation Office (“ATO”) for the tax years 2009 to 2013, we received Notices of Amended Assessments in March 2018. Based on these assessments, the ATO asserted that we owe $151.7 million in additional income tax and $38.4 million in accrued interest, of which $75.9 million was paid in April 2018 under a payment arrangement with the ATO. In June 2018, we received a notice from the ATO claiming penalties of 50% of the additional income tax that was assessed or $75.9 million. We do not agree with the ATO’s assessments and continue to believe we are more likely than not to be successful in defending our position. At September 30, 2018, we have recorded a receivable in prepaid taxes and other non-current assets for the amount paid as we ultimately expect this will be refunded by the ATO. The ATO are performing a risk review and auditing tax years 2014 to 2017. On December 22, 2017, the SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) directing taxpayers to consider the impact of the U.S. legislation as “provisional” when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, we recognized additional estimated income tax expense of $138.0 million during the year ended June 30, 2018 based on our best estimate and interpretation of the U.S. legislation. We are still accumulating data to finalize the underlying calculations, or in certain cases, the U.S. Treasury is expected to issue further guidance on the application of certain provisions of the U.S. legislation and recorded a further $0.5 million in income tax expense during three months ended September 30, 2018. In accordance with SAB 118, the estimated income tax expense is considered provisional and will be finalized before December 22, 2018.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Product Warranties

3 Months Ended

Sep. 30, 2018

Product Warranties [Abstract]

Product Warranties

(8) Product Warranties



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	19,227	$	19,558
Warranty accruals for the period		3,948		3,802
Warranty costs incurred for the period		(3,589)		(3,677)
Foreign currency translation adjustments		(261)		273
Balance at the end of the period	$	19,325	$	19,956

XML 25 R15.htm IDEA: XBRL DOCUMENT

Debt

3 Months Ended

Sep. 30, 2018

Debt [Abstract]

Debt

(9) Debt

Debt at September 30, 2018 and June 30, 2018 consisted of the following (in thousands):



	September 30, 2018		June 30, 2018
Short-term debt	$	12,000	$	12,000
Deferred borrowing costs		(25)		(534)
Short-term debt, net		11,975		11,466
		-
Long-term debt	$	520,000	$	272,000
Deferred borrowing costs		(2,363)		(2,012)
Long-term debt, net	$	517,637	$	269,988
Total debt	$	529,612	$	281,454

Credit Facility

XML 26 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

3 Months Ended

Sep. 30, 2018

Stockholders' Equity [Abstract]

Stockholders' Equity

(10) Stockholders’ Equity

The following table summarizes option activity during the three months ended September 30, 2018:



	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,205,826	$	60.48	4.4
Granted		-		-
Exercised		(11,973)		42.84
Forfeited		(183)		52.02
Outstanding at end of period		1,193,670	$	60.65	4.1
Exercise price of granted options	$	-
Options exercisable at end of period		671,647	$	52.43

The following table summarizes the activity of restricted stock units during the three months ended September 30, 2018:



	Restricted Stock Units		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,644,754	$	62.89	1.6
Granted		7,093		104.57
Vested		(2,911)		64.90
Expired / cancelled		(10,206)		63.80
Forfeited		(2,314)		63.80
Outstanding at end of period		1,636,416	$	63.08	1.4

XML 27 R17.htm IDEA: XBRL DOCUMENT

Earnings Per Share

3 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Earnings Per Share

(11) Earnings Per Share

Basic and diluted earnings per share for the three months ended September 30, 2018 and September 30, 2017 are calculated as follows (in thousands except per share data):



	Three Months Ended September 30,
	2018		2017
Numerator:
Net income	$	105,737	$	86,125
Denominator:
Basic weighted-average common shares outstanding		142,668		142,247
Effect of dilutive securities:
Stock options and restricted stock units		1,362		1,233
Diluted weighted average shares		144,030		143,480
Basic earnings per share	$	0.74	$	0.61
Diluted earnings per share	$	0.73	$	0.60

XML 28 R18.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Sep. 30, 2018

Fair Value Measurements [Abstract]

Fair Value Measurements

(12) Fair Value Measurements

The hierarchies of inputs are as follows:


	Level 1:	Input prices quoted in an active market for identical financial assets or liabilities;
	Level 2:	Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and
	Level 3	Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market.

The following table summarizes our financial assets and liabilities at September 30, 2018 and June 30, 2018, using the valuation input hierarchy (in thousands):



	Level 1		Level 2		Level 3		Total
Balances at September 30, 2018
Foreign currency hedging instruments, net	$	-	$	(587)	$	-	$	(587)
Business acquisition contingent consideration	$	-	$	-	$	(1,082)	$	(1,082)
Balances at June 30, 2018
Foreign currency hedging instruments, net	$	-	$	(2,699)	$	-	$	(2,699)
Business acquisition contingent consideration	$	-	$	-	$	(1,505)	$	(1,505)

We determine the fair value of our financial assets and liabilities as follows:

The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2018 and September 30, 2017 (in thousands):



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	(1,505)	$	(1,580)
Changes in fair value included in operating income		183		-
Payments		240		-
Balance at the end of the period	$	(1,082)	$	(1,580)

We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2018 or June 30, 2018.

XML 29 R19.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies

3 Months Ended

Sep. 30, 2018

Legal Actions And Contingencies [Abstract]

Legal Actions And Contingencies

(13) Legal Actions and Contingencies

Litigation

Taxation Matters

Contingent Obligations Under Recourse Provisions

The following table summarizes the amount of receivables sold with recourse during the three months ended September 30, 2018 and September 30, 2017(in thousands):



	Three Months Ended September 30,
	2018		2017
Total receivables sold:
Full recourse	$	10,082	$	4,200
Limited recourse		18,824		17,434
Total	$	28,906	$	21,634

The following table summarizes the maximum exposure on outstanding receivables sold with recourse and provision for doubtful accounts at September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018
Maximum exposure on outstanding receivables:
Full recourse	$	22,308	$	20,139
Limited recourse		10,190		9,239
Total	$	32,498	$	29,378

Contingent provision for receivables with recourse	$	(1,252)	$	(2,277)

XML 30 R20.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities

3 Months Ended

Sep. 30, 2018

Derivative Instruments And Hedging Activities [Abstract]

Derivative Instruments And Hedging Activities

(14) Derivative Instruments and Hedging Activities

The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2018 and June 30, 2018 (in thousands):



	September 30, 2018		June 30, 2018		Balance Sheet Caption
Foreign currency hedging instruments	$	1,299	$	281	Other assets - current
Foreign currency hedging instruments		(1,352)		(2,373)	Accrued expenses
Foreign currency hedging instruments		(534)		(607)	Other long-term liabilities
	$	(587)	$	(2,699)



	Gain /(Loss) Recognized				Income Statement Caption
	Three Months Ended September 30,
	2018		2017
Foreign currency hedging instruments	$	(1,699)	$	1,646	Other, net
Other foreign-currency-denominated transactions		887		(2,282)	Other, net
	$	(812)	$	(636)

XML 31 R21.htm IDEA: XBRL DOCUMENT

Business Combinations	3 Months Ended
Business Combinations	Sep. 30, 2018
Business Combinations [Abstract]
Business Combinations	(15) Business Combinations On July 6, 2018 we completed the acquisition of 100% of the shares in Healthcarefirst Holding Company (“Healthcarefirst”), a provider of software solutions and services for home health and hospice agencies, for a total purchase consideration of $126.3 million. This acquisition has been accounted for as a business combination using purchase accounting and is included in our consolidated financial statements from the acquisition date. The acquisition is not considered a material business combination and accordingly pro forma information is not provided. The acquisition was funded by drawing on our existing credit facility. The purchase price allocation associated with the Healthcarefirst acquisition is preliminary and we expect to complete this by the quarter ending June 30, 2019. We do not believe that the completion of this work will materially modify the preliminary purchase price allocation for Healthcarefirst. The cost of the acquisition was allocated to the assets acquired and liabilities assumed based on estimates of their fair values at the date of acquisition. The goodwill recognized as part of this acquisition of $125.0 million, which is not deductible for tax purposes, mainly represents the synergies that are unique to our combined businesses and the potential for new products and services to be developed in the future.

XML 32 R22.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Policy)

3 Months Ended

Sep. 30, 2018

Summary Of Significant Accounting Policies [Abstract]

Organization And Basis Of Presentation

Organization and Basis of Presentation

Revenue Recognition

Disaggregation of revenue



	Three Months Ended September 30,
	2018		2017
U.S., Canada and Latin America
Devices	$	172.4	$	157.9
Masks		154.0		138.7
Total devices and masks	$	326.4	$	296.6
Software as a Service		47.5		38.1
Total	$	373.9	$	334.7

Combined Europe, Asia and other markets
Devices	$	151.7	$	128.3
Masks		62.7		60.7
Total	$	214.4	$	189.0

Global revenue
Devices	$	324.1	$	286.2
Masks		216.7		199.4
Total devices and masks	$	540.8	$	485.6
Software as a Service		47.5		38.1
Total	$	588.3	$	523.7

Performance obligations and contract balances



	September 30, 2018		June 30, 2018		Balance sheet caption
Contract assets
Accounts receivable, net	$	463,743	$	483,681	Accounts receivable, net
Unbilled revenue, current		12,861		13,342	Prepaid expenses and other current assets
Unbilled revenue, non-current		3,718		2,973	Prepaid taxes and other non-current assets

Contract liabilities
Deferred revenue, current		(64,822)		(60,828)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(73,810)		(71,596)	Deferred revenue (non-current liabilities)

Transaction price determination

Accounting and practical expedient elections

Provision For Warranty

Provision for Warranty

New Accounting Pronouncements

(a) Recently issued accounting standards not yet adopted

ASU No. 2016-02, “Leases”

(b) Recently adopted accounting pronouncements

ASU No. 2014-09, “Revenue from Contracts with Customers”

ASU No. 2016-01, "Financial Instruments - Overall"

ASU No. 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory”



Balance Sheet Caption	As reported balance June 30, 2018		Adoption of ASU 2016-16 Increase/(Decrease)		Revised balance July 1, 2018
Assets
Prepaid expenses and other current assets	$	124,634	$	(28,947)	$	95,687
Prepaid taxes and other non-current assets		273,710		(156,406)		117,304
Deferred income taxes		53,818		(3,445)		50,373
Equity
Retained Earnings		2,432,328		(188,798)		2,243,530

XML 33 R23.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2018

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenue Disaggregated By Product And Region



	Three Months Ended September 30,
	2018		2017
U.S., Canada and Latin America
Devices	$	172.4	$	157.9
Masks		154.0		138.7
Total devices and masks	$	326.4	$	296.6
Software as a Service		47.5		38.1
Total	$	373.9	$	334.7

Combined Europe, Asia and other markets
Devices	$	151.7	$	128.3
Masks		62.7		60.7
Total	$	214.4	$	189.0

Global revenue
Devices	$	324.1	$	286.2
Masks		216.7		199.4
Total devices and masks	$	540.8	$	485.6
Software as a Service		47.5		38.1
Total	$	588.3	$	523.7

Summary Of Contract Balances



	September 30, 2018		June 30, 2018		Balance sheet caption
Contract assets
Accounts receivable, net	$	463,743	$	483,681	Accounts receivable, net
Unbilled revenue, current		12,861		13,342	Prepaid expenses and other current assets
Unbilled revenue, non-current		3,718		2,973	Prepaid taxes and other non-current assets

Contract liabilities
Deferred revenue, current		(64,822)		(60,828)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(73,810)		(71,596)	Deferred revenue (non-current liabilities)

Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16



Balance Sheet Caption	As reported balance June 30, 2018		Adoption of ASU 2016-16 Increase/(Decrease)		Revised balance July 1, 2018
Assets
Prepaid expenses and other current assets	$	124,634	$	(28,947)	$	95,687
Prepaid taxes and other non-current assets		273,710		(156,406)		117,304
Deferred income taxes		53,818		(3,445)		50,373
Equity
Retained Earnings		2,432,328		(188,798)		2,243,530

XML 34 R24.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

3 Months Ended

Sep. 30, 2018

Inventories [Abstract]

Schedule Of Inventories



	September 30, 2018		June 30, 2018
Raw materials	$	74,219	$	75,415
Work in progress		2,280		2,453
Finished goods		206,056		190,833
Total inventories	$	282,555	$	268,701

XML 35 R25.htm IDEA: XBRL DOCUMENT

Property, Plant And Equipment (Tables)

3 Months Ended

Sep. 30, 2018

Property, Plant And Equipment [Abstract]

Components Of Property, Plant And Equipment



	September 30, 2018		June 30, 2018
Machinery and equipment	$	242,079	$	239,671
Computer equipment		160,396		155,069
Furniture and fixtures		50,647		51,045
Vehicles		7,532		7,399
Clinical, demonstration and rental equipment		88,826		92,229
Leasehold improvements		32,437		32,169
Land		53,286		54,089
Buildings		226,602		229,193
		861,805		860,864
Accumulated depreciation and amortization		(479,983)		(474,314)
Property, plant and equipment, net	$	381,822	$	386,550

XML 36 R26.htm IDEA: XBRL DOCUMENT

Goodwill (Tables)

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule Of Changes In Carrying Amount Of Goodwill



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	1,068,944	$	1,064,874
Business acquisition		125,037		-
Foreign currency translation adjustments		(1,951)		7,424
Balance at the end of the period	$	1,192,030	$	1,072,298

XML 37 R27.htm IDEA: XBRL DOCUMENT

Other Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule Of Other Intangible Assets



	September 30, 2018		June 30, 2018
Developed/core product technology	$	229,533	$	205,149
Accumulated amortization		(122,505)		(115,237)
Developed/core product technology, net		107,028		89,912
Trade names		53,797		48,832
Accumulated amortization		(18,447)		(16,868)
Trade names, net		35,350		31,964
Non-compete agreements		3,255		3,288
Accumulated amortization		(2,366)		(2,283)
Non-compete agreements, net		889		1,005
Customer relationships		127,634		118,084
Accumulated amortization		(51,077)		(48,157)
Customer relationships, net		76,557		69,927
Patents		92,246		91,708
Accumulated amortization		(69,877)		(69,332)
Patents, net		22,369		22,376
Total other intangibles, net	$	242,193	$	215,184

XML 38 R28.htm IDEA: XBRL DOCUMENT

Equity Investments (Tables)

3 Months Ended

Sep. 30, 2018

Equity Investments [Abstract]

Schedule Of Reconciliation Of Changes In Equity Investments



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	41,226	$	38,324
Investments		2,467		3,225
Impairment of equity investments		(1,711)		(962)
Balance at the end of the period	$	41,982	$	40,587

XML 39 R29.htm IDEA: XBRL DOCUMENT

Product Warranties (Tables)

3 Months Ended

Sep. 30, 2018

Product Warranties [Abstract]

Schedule Of Changes In Liability For Warranty Costs



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	19,227	$	19,558
Warranty accruals for the period		3,948		3,802
Warranty costs incurred for the period		(3,589)		(3,677)
Foreign currency translation adjustments		(261)		273
Balance at the end of the period	$	19,325	$	19,956

XML 40 R30.htm IDEA: XBRL DOCUMENT

Debt (Tables)

3 Months Ended

Sep. 30, 2018

Debt [Abstract]

Schedule Of Debt



	September 30, 2018		June 30, 2018
Short-term debt	$	12,000	$	12,000
Deferred borrowing costs		(25)		(534)
Short-term debt, net		11,975		11,466
		-
Long-term debt	$	520,000	$	272,000
Deferred borrowing costs		(2,363)		(2,012)
Long-term debt, net	$	517,637	$	269,988
Total debt	$	529,612	$	281,454

XML 41 R31.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

3 Months Ended

Sep. 30, 2018

Stockholders' Equity [Abstract]

Schedule Of Option Activity



	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,205,826	$	60.48	4.4
Granted		-		-
Exercised		(11,973)		42.84
Forfeited		(183)		52.02
Outstanding at end of period		1,193,670	$	60.65	4.1
Exercise price of granted options	$	-
Options exercisable at end of period		671,647	$	52.43

Schedule Of Activity Of Restricted Stock Units



	Restricted Stock Units		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		1,644,754	$	62.89	1.6
Granted		7,093		104.57
Vested		(2,911)		64.90
Expired / cancelled		(10,206)		63.80
Forfeited		(2,314)		63.80
Outstanding at end of period		1,636,416	$	63.08	1.4

XML 42 R32.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Schedule Of Basic And Diluted Earnings Per Share



	Three Months Ended September 30,
	2018		2017
Numerator:
Net income	$	105,737	$	86,125
Denominator:
Basic weighted-average common shares outstanding		142,668		142,247
Effect of dilutive securities:
Stock options and restricted stock units		1,362		1,233
Diluted weighted average shares		144,030		143,480
Basic earnings per share	$	0.74	$	0.61
Diluted earnings per share	$	0.73	$	0.60

XML 43 R33.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2018

Fair Value Measurements [Abstract]

Summary Of Financial Assets And Liabilities



	Level 1		Level 2		Level 3		Total
Balances at September 30, 2018
Foreign currency hedging instruments, net	$	-	$	(587)	$	-	$	(587)
Business acquisition contingent consideration	$	-	$	-	$	(1,082)	$	(1,082)
Balances at June 30, 2018
Foreign currency hedging instruments, net	$	-	$	(2,699)	$	-	$	(2,699)
Business acquisition contingent consideration	$	-	$	-	$	(1,505)	$	(1,505)

Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs



	Three Months Ended September 30,
	2018		2017
Balance at the beginning of the period	$	(1,505)	$	(1,580)
Changes in fair value included in operating income		183		-
Payments		240		-
Balance at the end of the period	$	(1,082)	$	(1,580)

XML 44 R34.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies (Tables)

3 Months Ended

Sep. 30, 2018

Legal Actions And Contingencies [Abstract]

Summary Of Receivables Sold With Recourse



	Three Months Ended September 30,
	2018		2017
Total receivables sold:
Full recourse	$	10,082	$	4,200
Limited recourse		18,824		17,434
Total	$	28,906	$	21,634

Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision



	September 30, 2018		June 30, 2018
Maximum exposure on outstanding receivables:
Full recourse	$	22,308	$	20,139
Limited recourse		10,190		9,239
Total	$	32,498	$	29,378

Contingent provision for receivables with recourse	$	(1,252)	$	(2,277)

XML 45 R35.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Tables)

3 Months Ended

Sep. 30, 2018

Derivative Instruments And Hedging Activities [Abstract]

Summary Of Amount And Location Of Derivative Financial Instruments



	September 30, 2018		June 30, 2018		Balance Sheet Caption
Foreign currency hedging instruments	$	1,299	$	281	Other assets - current
Foreign currency hedging instruments		(1,352)		(2,373)	Accrued expenses
Foreign currency hedging instruments		(534)		(607)	Other long-term liabilities
	$	(587)	$	(2,699)

Summary Of Gains (Losses) Associated With Derivative Financial Instruments



	Gain /(Loss) Recognized				Income Statement Caption
	Three Months Ended September 30,
	2018		2017
Foreign currency hedging instruments	$	(1,699)	$	1,646	Other, net
Other foreign-currency-denominated transactions		887		(2,282)	Other, net
	$	(812)	$	(636)

XML 46 R36.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Narrative) (Details)	3 Months Ended
	Sep. 30, 2018
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Deferred revenue recognized over a period of	1 year
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Deferred revenue recognized over a period of	5 years

XML 47 R37.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
U.S., Canada And Latin America [Member]
Disaggregation of Revenue [Line Items]
Net revenue	$ 373.9	$ 334.7
U.S., Canada And Latin America [Member] \| Devices [Member]
Disaggregation of Revenue [Line Items]
Net revenue	172.4	157.9
U.S., Canada And Latin America [Member] \| Masks [Member]
Disaggregation of Revenue [Line Items]
Net revenue	154.0	138.7
U.S., Canada And Latin America [Member] \| Total Devices And Masks [Member]
Disaggregation of Revenue [Line Items]
Net revenue	326.4	296.6
U.S., Canada And Latin America [Member] \| Software As A Service [Member]
Disaggregation of Revenue [Line Items]
Net revenue	47.5	38.1
Combined Europe, Asia And Other Markets [Member]
Disaggregation of Revenue [Line Items]
Net revenue	214.4	189.0
Combined Europe, Asia And Other Markets [Member] \| Devices [Member]
Disaggregation of Revenue [Line Items]
Net revenue	151.7	128.3
Combined Europe, Asia And Other Markets [Member] \| Masks [Member]
Disaggregation of Revenue [Line Items]
Net revenue	62.7	60.7
Global [Member]
Disaggregation of Revenue [Line Items]
Net revenue	588.3	523.7
Global [Member] \| Devices [Member]
Disaggregation of Revenue [Line Items]
Net revenue	324.1	286.2
Global [Member] \| Masks [Member]
Disaggregation of Revenue [Line Items]
Net revenue	216.7	199.4
Global [Member] \| Total Devices And Masks [Member]
Disaggregation of Revenue [Line Items]
Net revenue	540.8	485.6
Global [Member] \| Software As A Service [Member]
Disaggregation of Revenue [Line Items]
Net revenue	$ 47.5	$ 38.1

XML 48 R38.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Contract assets
Accounts receivable, net	$ 463,743	$ 483,681
Contract liabilities
Deferred revenue, current	(64,822)	(60,828)
Deferred revenue, non-current	(73,810)	(71,596)
Accounts Receivable, Net [Member]
Contract assets
Accounts receivable, net	463,743	483,681
Prepaid Expenses And Other Current Assets [Member]
Contract assets
Unbilled revenue, current	12,861	13,342
Prepaid Taxes And Other Non Current Assets [Member]
Contract assets
Unbilled revenue, non-current	3,718	2,973
Deferred Revenue Current Liabilities [Member]
Contract liabilities
Deferred revenue, current	(64,822)	(60,828)
Deferred Revenue Non-Current Liabilities [Member]
Contract liabilities
Deferred revenue, non-current	$ (73,810)	$ (71,596)

XML 49 R39.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jul. 01, 2018	Jun. 30, 2018
Assets
Prepaid expenses and other current assets	$ 111,757		$ 124,634
Prepaid taxes and other non-current assets	117,024		273,710
Deferred income taxes	46,226		53,818
Equity
Retained earnings	$ 2,296,473		2,432,328
As Reported Balance [Member]
Assets
Prepaid expenses and other current assets			124,634
Prepaid taxes and other non-current assets			273,710
Deferred income taxes			53,818
Equity
Retained earnings			$ 2,432,328
Revised Balance [Member]
Assets
Prepaid expenses and other current assets		$ 95,687
Prepaid taxes and other non-current assets		117,304
Deferred income taxes		50,373
Equity
Retained earnings		2,243,530
ASU 2016-16 [Member] \| Adoption Of ASU 2016-16 Increase/(Decrease) [Member]
Assets
Prepaid expenses and other current assets		(28,947)
Prepaid taxes and other non-current assets		(156,406)
Deferred income taxes		(3,445)
Equity
Retained earnings		$ (188,798)

XML 50 R40.htm IDEA: XBRL DOCUMENT

Inventories (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Inventories [Abstract]
Raw materials	$ 74,219	$ 75,415
Work in progress	2,280	2,453
Finished goods	206,056	190,833
Total inventories	$ 282,555	$ 268,701

XML 51 R41.htm IDEA: XBRL DOCUMENT

Property, Plant And Equipment (Components Of Property, Plant And Equipment) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 861,805	$ 860,864
Accumulated depreciation and amortization	(479,983)	(474,314)
Property, plant and equipment, net	381,822	386,550
Machinery And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	242,079	239,671
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	160,396	155,069
Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	50,647	51,045
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	7,532	7,399
Clinical, Demonstration And Rental Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	88,826	92,229
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	32,437	32,169
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	53,286	54,089
Buildings [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 226,602	$ 229,193

XML 52 R42.htm IDEA: XBRL DOCUMENT

Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Balance at the beginning of the period	$ 1,068,944	$ 1,064,874
Business acquisition	125,037
Foreign currency translation adjustments	(1,951)	7,424
Balance at the end of the period	$ 1,192,030	$ 1,072,298

XML 53 R43.htm IDEA: XBRL DOCUMENT

Other Intangible Assets (Narrative) (Details)	3 Months Ended
Other Intangible Assets (Narrative) (Details)	Sep. 30, 2018
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, estimated useful life	2 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, estimated useful life	15 years

XML 54 R44.htm IDEA: XBRL DOCUMENT

Other Intangible Assets (Schedule Of Other Intangible Assets, Net) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Finite-Lived Intangible Assets [Line Items]
Total other intangibles, net	$ 242,193	$ 215,184
Developed/Core Product Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	229,533	205,149
Accumulated amortization	(122,505)	(115,237)
Total other intangibles, net	107,028	89,912
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	53,797	48,832
Accumulated amortization	(18,447)	(16,868)
Total other intangibles, net	35,350	31,964
Non-Compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	3,255	3,288
Accumulated amortization	(2,366)	(2,283)
Total other intangibles, net	889	1,005
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	127,634	118,084
Accumulated amortization	(51,077)	(48,157)
Total other intangibles, net	76,557	69,927
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	92,246	91,708
Accumulated amortization	(69,877)	(69,332)
Total other intangibles, net	$ 22,369	$ 22,376

XML 55 R45.htm IDEA: XBRL DOCUMENT

Equity Investments (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Equity Investments [Abstract]
Aggregate carrying amount of equity investments	$ 41,982	$ 40,587	$ 41,226	$ 38,324
Impairment losses related to cost-method investments	$ 1,711	$ 962

XML 56 R46.htm IDEA: XBRL DOCUMENT

Equity Investments (Schedule Of Reconciliation Of Changes In Equity Investments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Equity Investments [Abstract]
Balance at the beginning of the period	$ 41,226	$ 38,324
Investments	2,467	3,225
Impairment of equity investments	(1,711)	(962)
Balance at the end of the period	$ 41,982	$ 40,587

XML 57 R47.htm IDEA: XBRL DOCUMENT

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Apr. 30, 2018
Income Taxes [Line Items]
Income taxes payable	$ 160,427		$ 76,137	$ 160,427
Tax Year 2018 [Member] \| Scenario, Plan [Member]
Income Taxes [Line Items]
Income tax expense from transition tax			$ 500	$ 138,000
Australian Taxation Office [Member]
Income Taxes [Line Items]
Tax liabilities related to assessments	$ 75,900	$ 151,700
Interest related to assessments		$ 38,400
Percentage of penalties on additional income tax	50.00%
Income taxes payable					$ 75,900
Australian Taxation Office [Member] \| Minimum [Member]
Income Taxes [Line Items]
Tax year under audit		2009	2014
Australian Taxation Office [Member] \| Maximum [Member]
Income Taxes [Line Items]
Tax year under audit		2013	2017

XML 58 R48.htm IDEA: XBRL DOCUMENT

Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Product Warranties [Abstract]
Balance at the beginning of the period	$ 19,227	$ 19,558
Warranty accruals for the period	3,948	3,802
Warranty costs incurred for the period	(3,589)	(3,677)
Foreign currency translation adjustments	(261)	273
Balance at the end of the period	$ 19,325	$ 19,956

XML 59 R49.htm IDEA: XBRL DOCUMENT

Debt (Narrative) (Details) - USD ($) $ in Thousands					3 Months Ended
Debt (Narrative) (Details) - USD ($) $ in Thousands	Apr. 17, 2018	Jan. 09, 2017	Apr. 04, 2016	Oct. 31, 2013	Sep. 30, 2018	Jun. 30, 2018
Debt Instrument [Line Items]
Outstanding under the revolving credit facility and term credit facility					$ 529,612	$ 281,454
Union Bank, N.A. and HSBC Bank USA [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 1,000,000	$ 700,000
Uncommitted option to increase credit facility			$ 300,000	$ 300,000
MUFG Union Bank [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,300,000
Uncommitted option to increase credit facility		$ 300,000
Credit facility termination date		Oct. 31, 2018
MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 800,000
Uncommitted option to increase credit facility	300,000
MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| Revolving Credit Facility And Term Credit Agreement [Member]
Debt Instrument [Line Items]
Credit facility termination date					Apr. 17, 2023
Interest rate on outstanding principal amount					3.00%
Outstanding under the revolving credit facility and term credit facility					$ 529,600
MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| ResMed Limited [Member] \| Term Credit Agreement [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 200,000
Principal payment					$ 6,000
Frequency of payments					semi-annual
Minimum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Commitment fees percentage rate on unused portion of credit facility					0.10%
Minimum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| ResMed Limited [Member] \| Term Credit Agreement [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Credit facility interest rate equal to reference rate plus					0.75%
Minimum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| ResMed Limited [Member] \| Term Credit Agreement [Member] \| Base Rate [Member]
Debt Instrument [Line Items]
Credit facility interest rate equal to reference rate plus					0.00%
Maximum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Commitment fees percentage rate on unused portion of credit facility					0.175%
Maximum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| ResMed Limited [Member] \| Term Credit Agreement [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Credit facility interest rate equal to reference rate plus					1.50%
Maximum [Member] \| MUFG Union Bank, N.A. and Westpac Banking Corporation [Member] \| ResMed Limited [Member] \| Term Credit Agreement [Member] \| Base Rate [Member]
Debt Instrument [Line Items]
Credit facility interest rate equal to reference rate plus					0.50%

XML 60 R50.htm IDEA: XBRL DOCUMENT

Debt (Schedule Of Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Debt [Abstract]
Short-term debt	$ 12,000	$ 12,000
Deferred borrowing costs	(25)	(534)
Short-term debt, net	11,975	11,466
Long-term debt	520,000	272,000
Deferred borrowing costs	(2,363)	(2,012)
Long-term debt, net	517,637	269,988
Total debt	$ 529,612	$ 281,454

XML 61 R51.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Sep. 30, 2018	Jun. 30, 2018	Apr. 30, 1997
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares repurchased under repurchase program	200,000
Cost of common shares repurchased	$ 22,800
Total number of shares repurchased pursuant to the repurchase program	41,836,234	41,636,234
Total cost of shares repurchased pursuant to the repurchase program	$ 1,623,256	$ 1,600,412
Additional shares that can be repurchased under the approved share repurchase program	12,900,000
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock at par value	$ 0.01	$ 0.01
Preferred stock, shares issued	0	0
Series A Junior Participating Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized			2,000,000
Preferred stock at par value			$ 0.01
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
2009 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	7 years
Common stock authorized for issuance	51,100,000
Number of securities remaining available for future issuance	17,800,000
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities remaining available for future issuance	500,000
Minimum [Member] \| 2009 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Maximum [Member] \| 2009 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	4 years

XML 62 R52.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Schedule Of Option Activity) (Details) - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018
Stockholders' Equity [Abstract]
Options, Outstanding at beginning of period	1,205,826
Options, Granted
Options, Exercised	(11,973)
Options, Forfeited	(183)
Options, Outstanding at end of period	1,193,670	1,205,826
Options, Exercise price of granted options
Options exercisable at end of period	671,647
Weighted Average Exercise Price, Outstanding at beginning of period	$ 60.48
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised	42.84
Weighted Average Exercise Price, Forfeited	52.02
Weighted Average Exercise Price, Outstanding at end of period	60.65	$ 60.48
Weighted Average Exercise Price, Options exercisable at end of period	$ 52.43
Weighted Average Remaining Contractual Term in Years, Outstanding	4 years 1 month 6 days	4 years 4 months 24 days

XML 63 R53.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2018	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units, Outstanding at beginning of period	1,644,754
Restricted Stock Units, Granted	7,093
Restricted Stock Units, Vested	(2,911)
Restricted Stock Units, Expired / cancelled	(10,206)
Restricted Stock Units, Forfeited	(2,314)
Restricted Stock Units, Outstanding at end of period	1,636,416	1,644,754
Weighted Average Grant-Date Fair Value, Outstanding at beginning of period	$ 62.89
Weighted Average Grant-Date Fair Value, Granted	104.57
Weighted Average Grant-Date Fair Value, Vested	64.90
Weighted Average Grant-Date Fair Value, Expired / cancelled	63.80
Weighted Average Grant-Date Fair Value, Forfeited	63.80
Weighted Average Grant-Date Fair Value, Outstanding at end of period	$ 63.08	$ 62.89
Weighted Average Remaining Contractual Term in Years, Outstanding	1 year 4 months 24 days	1 year 7 months 6 days

XML 64 R54.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Narrative) (Details) - shares	3 Months Ended
Earnings Per Share (Narrative) (Details) - shares	Sep. 30, 2018	Sep. 30, 2017
Earnings Per Share [Abstract]
Stock options and restricted stock units not included in the computation of diluted earnings per share	10,006	6,982

XML 65 R55.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Numerator:
Net income	$ 105,737	$ 86,125
Denominator:
Basic weighted-average common shares outstanding	142,668	142,247
Effect of dilutive securities:
Stock options and restricted stock units	1,362	1,233
Diluted weighted average shares	144,030	143,480
Basic earnings per share	$ 0.74	$ 0.61
Diluted earnings per share	$ 0.73	$ 0.60

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 66 R56.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net	$ (587)	$ (2,699)
Business acquisition contingent consideration	(1,082)	(1,505)
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net
Business acquisition contingent consideration
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net	(587)	(2,699)
Business acquisition contingent consideration
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net
Business acquisition contingent consideration	$ (1,082)	$ (1,505)

XML 67 R57.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Fair Value Measurements [Abstract]
Balance at the beginning of the period	$ (1,505)	$ (1,580)
Changes in fair value included in operating income	183
Payments	240
Balance at the end of the period	$ (1,082)	$ (1,580)

XML 68 R58.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2018	Apr. 30, 2018
Loss Contingencies [Line Items]
Income taxes payable	$ 160,427		$ 76,137
Australian Taxation Office [Member]
Loss Contingencies [Line Items]
Percentage of penalties on additional income tax	50.00%
Income taxes payable				$ 75,900
Tax liabilities related to assessments	$ 75,900	$ 151,700
Interest related to assessments		$ 38,400
Minimum [Member] \| Australian Taxation Office [Member]
Loss Contingencies [Line Items]
Tax year under audit		2009	2014
Maximum [Member] \| Australian Taxation Office [Member]
Loss Contingencies [Line Items]
Tax year under audit		2013	2017

XML 69 R59.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies (Summary Of Receivables Sold With Recourse) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Contingent Obligations Under Recourse Provisions [Line Items]
Total receivables sold	$ 28,906	$ 21,634
Full Recourse [Member]
Contingent Obligations Under Recourse Provisions [Line Items]
Total receivables sold	10,082	4,200
Limited Recourse [Member]
Contingent Obligations Under Recourse Provisions [Line Items]
Total receivables sold	$ 18,824	$ 17,434

XML 70 R60.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies (Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Contingent Obligations Under Recourse Provisions [Line Items]
Maximum exposure on outstanding receivables	$ 32,498	$ 29,378
Contingent provision for receivables with recourse	(1,252)	(2,277)
Full Recourse [Member]
Contingent Obligations Under Recourse Provisions [Line Items]
Maximum exposure on outstanding receivables	22,308	20,139
Limited Recourse [Member]
Contingent Obligations Under Recourse Provisions [Line Items]
Maximum exposure on outstanding receivables	$ 10,190	$ 9,239

XML 71 R61.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2018	Jun. 30, 2018
Derivative [Line Items]
Notional amount of foreign currency hedging contracts held	$ 530.2	$ 462.1
Foreign Currency Hedging Instruments [Member]
Derivative [Line Items]
Terms of foreign currency hedging contracts, maximum	3 years
Maturity date	Dec. 31, 2019

XML 72 R62.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) - Derivatives Not Designated As Hedging Instruments [Member] - Foreign Currency Hedging Instruments [Member] - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Derivatives, Fair Value [Line Items]
Net foreign currency hedging instruments	$ (587)	$ (2,699)
Other Assets - Current [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, assets	1,299	281
Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, liabilities	(1,352)	(2,373)
Other Long-Term Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, liabilities	$ (534)	$ (607)

XML 73 R63.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) - Derivatives Not Designated As Hedging Instruments [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) recognized in income	$ (812)	$ (636)
Foreign Currency Hedging Instruments [Member] \| Other, Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency hedging instruments	(1,699)	1,646
Other Foreign-Currency-Denominated Transactions [Member] \| Other, Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other foreign-currency-denominated transactions	$ 887	$ (2,282)

XML 74 R64.htm IDEA: XBRL DOCUMENT

Business Combinations (Narrative) (Details) - Healthcarefirst [Member] - USD ($) $ in Millions		3 Months Ended
	Jul. 06, 2018	Sep. 30, 2018
Business Combinations [Line Items]
Date of acquisition agreement		Jul. 06, 2018
Percentage of acquisition shares	100.00%
Total purchase price of acquisition	$ 126.3
Goodwill from acquisition, non-tax deductible amount	$ 125.0

EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 147 237 1 false 60 0 false 4 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://investor.resmed.com/2011-03-31/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://investor.resmed.com/2011-03-31/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://investor.resmed.com/2011-03-31/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements Of Income Sheet http://investor.resmed.com/2011-03-31/role/StatementCondensedConsolidatedStatementsOfIncome Condensed Consolidated Statements Of Income Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements Of Comprehensive Income Sheet http://investor.resmed.com/2011-03-31/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements Of Comprehensive Income Statements 5 false false R6.htm 00500 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://investor.resmed.com/2011-03-31/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Summary Of Significant Accounting Policies Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies Notes 7 false false R8.htm 10201 - Disclosure - Inventories Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventories Inventories Notes 8 false false R9.htm 10301 - Disclosure - Property, Plant And Equipment Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipment Property, Plant And Equipment Notes 9 false false R10.htm 10401 - Disclosure - Goodwill Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwill Goodwill Notes 10 false false R11.htm 10501 - Disclosure - Other Intangible Assets Sheet http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssets Other Intangible Assets Notes 11 false false R12.htm 10601 - Disclosure - Equity Investments Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestments Equity Investments Notes 12 false false R13.htm 10701 - Disclosure - Income Taxes Sheet http://investor.resmed.com/2011-03-31/role/DisclosureIncomeTaxes Income Taxes Notes 13 false false R14.htm 10801 - Disclosure - Product Warranties Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarranties Product Warranties Notes 14 false false R15.htm 10901 - Disclosure - Debt Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDebt Debt Notes 15 false false R16.htm 11001 - Disclosure - Stockholders' Equity Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 11101 - Disclosure - Earnings Per Share Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShare Earnings Per Share Notes 17 false false R18.htm 11201 - Disclosure - Fair Value Measurements Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 11301 - Disclosure - Legal Actions And Contingencies Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingencies Legal Actions And Contingencies Notes 19 false false R20.htm 11401 - Disclosure - Derivative Instruments And Hedging Activities Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivities Derivative Instruments And Hedging Activities Notes 20 false false R21.htm 11501 - Disclosure - Business Combinations Sheet http://investor.resmed.com/2011-03-31/role/DisclosureBusinessCombinations Business Combinations Notes 21 false false R22.htm 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy Summary Of Significant Accounting Policies (Policy) Policies http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 30103 - Disclosure - Summary Of Significant Accounting Policies (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary Of Significant Accounting Policies (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 30203 - Disclosure - Inventories (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesTables Inventories (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureInventories 24 false false R25.htm 30303 - Disclosure - Property, Plant And Equipment (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentTables Property, Plant And Equipment (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipment 25 false false R26.htm 30403 - Disclosure - Goodwill (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillTables Goodwill (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureGoodwill 26 false false R27.htm 30503 - Disclosure - Other Intangible Assets (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssetsTables Other Intangible Assets (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssets 27 false false R28.htm 30603 - Disclosure - Equity Investments (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestmentsTables Equity Investments (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestments 28 false false R29.htm 30803 - Disclosure - Product Warranties (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesTables Product Warranties (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureProductWarranties 29 false false R30.htm 30903 - Disclosure - Debt (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDebtTables Debt (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureDebt 30 false false R31.htm 31003 - Disclosure - Stockholders' Equity (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquity 31 false false R32.htm 31103 - Disclosure - Earnings Per Share (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShare 32 false false R33.htm 31203 - Disclosure - Fair Value Measurements (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurements 33 false false R34.htm 31303 - Disclosure - Legal Actions And Contingencies (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesTables Legal Actions And Contingencies (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingencies 34 false false R35.htm 31403 - Disclosure - Derivative Instruments And Hedging Activities (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments And Hedging Activities (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivities 35 false false R36.htm 40101 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails Summary Of Significant Accounting Policies (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 40102 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNetRevenueDisaggregatedByProductAndRegionDetails Summary Of Significant Accounting Policies (Summary Of Net Revenue Disaggregated By Product And Region) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 40103 - Disclosure - Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfContractBalancesDetails Summary Of Significant Accounting Policies (Summary Of Contract Balances) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 40104 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfReclassificationOfAssetsAndEquityUponAdoptionAsu201616Details Summary Of Significant Accounting Policies (Schedule Of Reclassification Of Assets And Equity Upon Adoption ASU 2016-16) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 40201 - Disclosure - Inventories (Schedule Of Inventories) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesScheduleOfInventoriesDetails Inventories (Schedule Of Inventories) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesTables 40 false false R41.htm 40301 - Disclosure - Property, Plant And Equipment (Components Of Property, Plant And Equipment) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentComponentsOfPropertyPlantAndEquipmentDetails Property, Plant And Equipment (Components Of Property, Plant And Equipment) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentTables 41 false false R42.htm 40402 - Disclosure - Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillScheduleOfChangesInCarryingAmountOfGoodwillDetails Goodwill (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillTables 42 false false R43.htm 40501 - Disclosure - Other Intangible Assets (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssetsNarrativeDetails Other Intangible Assets (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssetsTables 43 false false R44.htm 40502 - Disclosure - Other Intangible Assets (Schedule Of Other Intangible Assets, Net) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssetsScheduleOfOtherIntangibleAssetsNetDetails Other Intangible Assets (Schedule Of Other Intangible Assets, Net) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureOtherIntangibleAssetsTables 44 false false R45.htm 40601 - Disclosure - Equity Investments (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestmentsNarrativeDetails Equity Investments (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestmentsTables 45 false false R46.htm 40602 - Disclosure - Equity Investments (Schedule Of Reconciliation Of Changes In Equity Investments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestmentsScheduleOfReconciliationOfChangesInEquityInvestmentsDetails Equity Investments (Schedule Of Reconciliation Of Changes In Equity Investments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEquityInvestmentsTables 46 false false R47.htm 40701 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureIncomeTaxes 47 false false R48.htm 40801 - Disclosure - Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesScheduleOfChangesInLiabilityForWarrantyCostsDetails Product Warranties (Schedule Of Changes In Liability For Warranty Costs) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesTables 48 false false R49.htm 40901 - Disclosure - Debt (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDebtNarrativeDetails Debt (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDebtTables 49 false false R50.htm 40902 - Disclosure - Debt (Schedule Of Debt) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDebtScheduleOfDebtDetails Debt (Schedule Of Debt) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDebtTables 50 false false R51.htm 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 51 false false R52.htm 41002 - Disclosure - Stockholders' Equity (Schedule Of Option Activity) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityScheduleOfOptionActivityDetails Stockholders' Equity (Schedule Of Option Activity) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 52 false false R53.htm 41003 - Disclosure - Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityScheduleOfActivityOfRestrictedStockUnitsDetails Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 53 false false R54.htm 41101 - Disclosure - Earnings Per Share (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareNarrativeDetails Earnings Per Share (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables 54 false false R55.htm 41102 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables 55 false false R56.htm 41202 - Disclosure - Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesDetails Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables 56 false false R57.htm 41203 - Disclosure - Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsReconciliationForFairValueMeasurementsUsingSignificantUnobservableInputsDetails Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables 57 false false R58.htm 41301 - Disclosure - Legal Actions And Contingencies (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesNarrativeDetails Legal Actions And Contingencies (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesTables 58 false false R59.htm 41302 - Disclosure - Legal Actions And Contingencies (Summary Of Receivables Sold With Recourse) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesSummaryOfReceivablesSoldWithRecourseDetails Legal Actions And Contingencies (Summary Of Receivables Sold With Recourse) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesTables 59 false false R60.htm 41303 - Disclosure - Legal Actions And Contingencies (Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesSummaryOfMaximumExposureOnOutstandingReceivablesSoldWithRecourseAndProvisionDetails Legal Actions And Contingencies (Summary Of Maximum Exposure On Outstanding Receivables Sold With Recourse And Provision) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesTables 60 false false R61.htm 41401 - Disclosure - Derivative Instruments And Hedging Activities (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNarrativeDetails Derivative Instruments And Hedging Activities (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 61 false false R62.htm 41402 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesSummaryOfAmountAndLocationOfDerivativeFinancialInstrumentsDetails Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 62 false false R63.htm 41403 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesSummaryOfGainsLossesAssociatedWithDerivativeFinancialInstrumentsDetails Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 63 false false R64.htm 41501 - Disclosure - Business Combinations (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureBusinessCombinationsNarrativeDetails Business Combinations (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureBusinessCombinations 64 false false All Reports Book All Reports rmd-20180930.xml rmd-20180930.xsd rmd-20180930_cal.xml rmd-20180930_def.xml rmd-20180930_lab.xml rmd-20180930_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 81 0000943819-18-000016-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000943819-18-000016-xbrl.zip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�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a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